An isoprene derivative photoaffinity probe, its preparation method and application
By introducing a bisacrylidine photoreactive group and an alkynyl bioorthogonal group into the isoprenyl carbon chain end of the isoprenyl derivative probe, the functional influence and covalent capture problem of existing probe tools when capturing weak interactions are solved, and efficient labeling and systematic study of isoprenyled proteins and vitamin K binding proteins are realized.
Patent Information
- Application Number
- CN202611314356.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-27
- Publication Date
- 2026-11-17
AI Technical Summary
Existing probe tools suffer from structural modifications that affect function or prevent covalent capture when capturing weak or transient protein interactions, and there are limited tools available for systematically studying isopentenylated protein networks and vitamin K interactomes.
A class of isoprene derivative photoaffinity probes were designed. By introducing a diacaridine photoreactive group and an alkynyl bioorthogonal group at the end of the isoprene carbon chain, the probes mimic natural isoprene ligands and are used to efficiently enter living cells and achieve fluorescence imaging analysis and high-throughput proteomics identification.
This method enables efficient labeling and covalent cross-linking of isopentenylated proteins and vitamin K-binding proteins, allowing for systematic study of intracellular isopentenylated proteins and their interaction networks. It supports multiple detection platforms and has significant theoretical and practical value.
Smart Images

Figure CN123106533A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biodetection and analysis technology, specifically relating to an isoprene derivative photoaffinity probe, its preparation method, and its application. Background Technology
[0002] The information disclosed in this background section is intended only to enhance understanding of the overall background of the invention and is not necessarily to be construed as an admission or in any way implying that such information constitutes prior art known to those skilled in the art.
[0003] Isoprenes and their derivatives play crucial roles in life activities. Protein isoprenylation is an important post-translational modification of lipids, catalyzed by isoprenyltransferases, which link farnesyl pyrophosphate or geraniylgeraniyl pyrophosphate to the C-terminal cysteine residue of proteins. This modification promotes protein membrane localization, thereby regulating key physiological processes such as signal transduction, cell growth, and differentiation. Abnormalities in isoprenylation are closely related to the development and progression of various diseases. Furthermore, vitamin K, a fat-soluble vitamin, also contains isoprenyl side chains in its molecular structure. Through the redox cycle of the naphthoquinone ring, it participates in various important functions, including coagulation, bone metabolism, inhibition of tissue calcification, and regulation of ferroptosis.
[0004] Although many isopentenylated proteins and vitamin K targets have been identified, systematic studies of their interactions with other proteins (i.e., interacting proteins) remain insufficient, limiting a deeper understanding of related biological pathways and drug mechanisms. Traditional methods such as affinity purification have limitations in capturing weak / transient interactions. Emerging chemical proteomics methods, particularly photoaffinity labeling techniques, have provided powerful tools for studying these interactions. However, the probe tools currently available for systematically studying isopentenylated protein networks and the vitamin K interactome remain very limited. Existing probes either suffer from problems such as excessive structural modification affecting function, inability to achieve covalent capture, or limited application scenarios. Summary of the Invention
[0005] To address the shortcomings of the existing technologies, this invention provides an isoprene derivative photoaffinity probe, its preparation method, and its applications. Specifically, this invention provides a novel type of isoprene derivative photoaffinity probe with a simplified structure that can mimic natural isoprene ligands (such as farnesol, geraniol, and the isoprene side chain of vitamin K), efficiently entering living cells and participating in related biological processes (such as protein isoprene modification and interaction with vitamin K-binding proteins), thereby enabling fluorescence imaging analysis and high-throughput proteomics identification of target proteins. This invention is based on the above research findings.
[0006] Specifically, the present invention relates to the following technical solutions: In a first aspect, the present invention provides an isoprene derivative photoaffinity probe, wherein the isoprene derivative photoaffinity probe can be a photoaffinity geraniol probe (GOHP), a photoaffinity farnesol probe (FOHP), or a vitamin K2 photoaffinity probe (MK2P), and the specific structural formula is as follows: .
[0007] Specifically, the above-mentioned photoaffinity probes introduce a photoreactive group (bisacrididine) and an alkynyl group into a backbone containing two isopentenyl units (simulating the structure of farnesol or geraniol) to prepare photoaffinity geraniol probes (GOHP) and photoaffinity farnesol probes (FOHP); and introduce a photoreactive group (bisacrididine) and an alkynyl group into the isopentenyl side chain of vitamin K2 (containing two isopentenyl units, simulating the MK4 side chain) to prepare vitamin K2 photoaffinity probes (MK2P).
[0008] A second aspect of the present invention provides a method for preparing the above-mentioned isoprene derivative photoaffinity probe, the method comprising: S1. Protect the hydroxyl group of geraniol or farnesol with a tetrahydropyranyl group to obtain compound 1; S2. The allyl position of compound 1 was oxidized with selenium dioxide and tert-butyl hydroperoxide, and then reduced with sodium borohydride to obtain compound 2 with a terminal hydroxyl group. S3. The terminal hydroxyl group of compound 2 was brominated using N-bromosuccinimide and dimethyl sulfide to give compound 3; S4. Ethyl acetoacetate was coupled with 3-bromo-1-(trimethylsilyl)-1-propyne in the presence of lithium diisopropylamino to obtain ketoester compound 4 containing an alkyne group. S5. Compound 3 and compound 4 are coupled in the presence of sodium hydride, and then decarboxylated by saponification to obtain compound 5. S6. Remove the tetrahydropyran protecting group of compound 5 to obtain compound 6; S7. The ketone group of compound 6 was successively treated with ammonia-methanol, hydroxylamine-O-sulfonic acid oxime and iodine oxidation cyclization to introduce a diacylpyridinium group, thus obtaining compound 7, namely photoaffinity geraniol probe or photoaffinity farnesol probe. Furthermore, the preparation method further includes: coupling compound 7 photoaffinity geraniol probe with the reduction product of menaquinone under the catalysis of boron trifluoride diethyl ether to obtain vitamin K2 photoaffinity probe.
[0009] Furthermore, the preparation method includes the following synthetic route: ; Furthermore, the synthetic route also includes: .
[0010] A third aspect of the present invention provides a detection kit, the kit comprising at least the probe described above. Furthermore, the detection kit may also comprise any other known reagents (such as reaction enhancers, enzyme reagents, buffer solutions, washing solutions, etc.), without specific limitations herein.
[0011] A fourth aspect of the present invention provides the application of the above-described probe or detection kit in protein labeling and identification; wherein the protein includes isopentenylated modified protein and / or vitamin K binding protein.
[0012] Furthermore, the applications include: co-incubating the probe with cells to modify proteins by isopentenylation or bind to vitamin K-binding proteins within the cells; covalently crosslinking the probe with its binding protein via a diaziridine group after ultraviolet irradiation; introducing a fluorescent group or biotin onto the alkyne group of the probe via a click chemistry reaction; and using it for fluorescence gel imaging analysis, cell fluorescence imaging analysis, or proteomics mass spectrometry analysis after streptavidin enrichment.
[0013] The wavelength of the ultraviolet irradiation can be 365 nm; the fluorescent group is selected from Rhodamine B-PEG3-azide; and the biotin is selected from biotin-DADPS-azide.
[0014] Furthermore, when the probe is co-incubated with cells, lovastatin is added to inhibit the synthesis of endogenous isoprene, thereby enhancing the labeling efficiency of the probe for protein isoprene modification.
[0015] Furthermore, the applications include research on the mechanisms of action of drugs related to the isopentenyl pathway (such as statins and bisphosphonates).
[0016] Furthermore, the application also includes studying the distribution of vitamin K within cells.
[0017] In one specific embodiment of the present invention, the cells are HEK 293T cells, HT1080 cells, or OVCAR8 cells.
[0018] The beneficial technical effects of one or more of the above technical solutions: The aforementioned technical solution uses the isopentenyl group as a universal backbone. By introducing a diacylpropidine photoreactive group and an alkyne bioorthogonal group at the carbon chain end, a class of isopentenyl derivative probes are constructed. These probes can be used for research on protein isopentenylation modification and vitamin K binding proteins. Furthermore, both diacylpropidine and the alkyne group are small molecule modifying groups, and their introduction has minimal impact on the original biological functions of the isopentenyl group or vitamin K, thus better mimicking the interaction between natural molecules and proteins. These probes can be used on various detection platforms, including fluorescence gel imaging, cell fluorescence imaging, and proteomics mass spectrometry analysis. They enable systematic research on intracellular isopentenylated proteins and their interacting protein networks, as well as the vitamin K interacting proteome. They have significant theoretical and applied value in the study of isopentenyl pathway-related drugs (such as statins and bisphosphonates) and the biological functions of vitamin K. Attached Figure Description
[0019] The accompanying drawings, which form part of this invention, are used to provide a further understanding of the invention. The illustrative embodiments of the invention and their descriptions are used to explain the invention and do not constitute an improper limitation of the invention.
[0020] Figure 1 This describes the design of the photoaffinity geraniol and farnesol probes and the photoaffinity geraniol and farnesol pyrophosphate probes in Example 1 of the present invention.
[0021] Figure 2 This describes the labeling principle and application of the photoaffinity probe in Embodiment 1 of the present invention.
[0022] Figure 3 This is a schematic diagram of fluorescent gel imaging of cells labeled with photoaffinity geraniol probe in Example 1 of the present invention.
[0023] Figure 4 This is an example of the labeling of HEK293T cells by the photoaffinity geraniol probe under different conditions in Example 1 of the present invention.
[0024] Figure 5 This is a schematic diagram of the preparation and detection of HEK 293 T cell mass spectrometry samples labeled with geraniol photoaffinity probe in Example 1 of the present invention.
[0025] Figure 6 Fluorescent gel imaging and mass spectrometry analysis of probe labeling under different conditions in Example 1 of the present invention; (a) Fluorescent gel showing the effect of probe labeling in four sets of experiments; (b) Venn diagram comparing proteins commonly identified in three sets of biological replicates under different experimental conditions.
[0026] Figure 7 This is a comparison of the labeling effects of isopentenyl-related proteins reported in the four experimental groups (ad) in Example 1 of this invention.
[0027] Figure 8 This is a flowchart of the geraniol photoaffinity probe-labeled cell imaging process in Example 1 of the present invention.
[0028] Figure 9 This is an example of cell labeling and imaging using the photoaffinity geraniol probe (GOHP) in Example 1 of the present invention.
[0029] Figure 10 The design of MK2P and MK2CP in Example 2 of the present invention; (a) the structure of vitamin K2 (MK4) and its derivative MK2; (b) the structure of vitamin K2 photoaffinity probe (MK2P) and vitamin K2 control probe (MK2CP).
[0030] Figure 11 This is a flowchart illustrating the principle and flowchart of MK2P labeling and analysis of vitamin K-interacting proteins in Example 2 of the present invention.
[0031] Figure 12 The ultraviolet absorption measurements of MK2, MK2P, and MK2CP in Example 2 of this invention are shown below: (a) Ultraviolet absorption spectra of MK2 standard solution and probe test solution in the range of 235-400 nm; (b) Ultraviolet absorption standard curve of MK2 at 262 nm.
[0032] Figure 13 This is a schematic diagram of fluorescent gel imaging of MK2P-labeled cells in Example 2 of the present invention.
[0033] Figure 14 This illustrates the effect of different conditions on MK2P labeling in Example 2 of the present invention. (a) Fluorescent gel imaging results of HEK293T cells labeled with different concentrations of MK2P; (b) Fluorescent gel imaging results of HEK293T cells labeled with MK2P incubation for different times; (c) Fluorescent gel imaging results of MK2P irradiation for different times. Except for the conditions marked in the figures, the probe incubation time was 4 hours, the irradiation time was 5 minutes, and the click chemical reaction time was 3 hours.
[0034] Figure 15 This illustrates the competitive effect of different concentrations of MK2 and MK4 on MK2P labeling in Example 2 of the present invention.
[0035] Figure 16 This is an example of the fluorescent gel labeling effect of MK2CP in Example 2 of the present invention. (a) Comparison of HEK293T cells labeled with MK2P and MK2CP; (b) Labeling results of HEK293T cells with different concentrations of MK2CP; (c) Labeling results of HEK293T cells after incubation with MK2CP for different times; (d) Competitive effect of different concentrations of MK4 on MK2CP labeling. Except for the conditions indicated in the figure, the probe concentration was 10 μmol / L, the incubation time was 4 hours, and the click chemistry reaction time was 3 hours.
[0036] Figure 17 This is a schematic diagram of the preparation and detection of MK2P-labeled HEK293 T cell mass spectrometry samples in Example 2 of the present invention.
[0037] Figure 18 Mass spectrometry data analysis of MK4 competing with MK2P labeling in Example 2 of the present invention; (a) Venn diagram showing the comparison of proteins identified in five biological replicates of the MK2P+MK4 competition experiment; (b) Volcano diagram showing the quantitative results of this set of experiments.
[0038] Figure 19 Mass spectrometry data analysis of MK2 competing with MK2P labeling in Example 2 of the present invention; (a) Venn diagram showing the comparison of proteins identified in five biological replicates of the MK2P+MK2 competition experiment; (b) Volcano diagram showing the quantitative results of this set of experiments.
[0039] Figure 20 This is a flowchart of MK2P-labeled cell imaging in Embodiment 2 of the present invention.
[0040] Figure 21 This invention provides an example of MK2P labeling and imaging experiments on two different cell lines in Example 2. The labeling and imaging analysis of (a) OVCAR-8 cells and (b) HT1080 cells were performed using 10 μmol / L MK2P. Imaging was performed using a 10× objective lens after 5 minutes of 365 nm UV irradiation.
[0041] Figure 22 This illustrates the competitive effect of MK2 and MK4 on MK2P-labeled OVCAR-8 cells in Example 2 of this invention.
[0042] Figure 23 This illustrates the effect of ultraviolet irradiation on MK2P-labeled cell imaging in Example 2 of the present invention.
[0043] Figure 24 This is a co-localization analysis of MK2P with different organelles in Example 2 of the present invention. Detailed Implementation
[0044] It should be noted that the following detailed descriptions are illustrative and intended to provide further explanation of this application. Unless otherwise specified, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application pertains.
[0045] It should be noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to limit the exemplary embodiments according to this application. As used herein, the singular form is intended to include the plural form as well, unless the context clearly indicates otherwise. Furthermore, it should be understood that when the terms "comprising" and / or "including" are used in this specification, they indicate the presence of features, steps, operations, devices, components, and / or combinations thereof. Experimental methods in the following detailed embodiments, unless specific conditions are specified, generally follow conventional methods and conditions within the art, which are fully explained in the literature.
[0046] The present invention will be further illustrated with specific examples. These examples are for illustrative purposes only and do not limit the scope of the invention. Unless otherwise specified, experimental conditions not explicitly stated in the examples are generally performed under conventional conditions or as recommended by the selling company. Materials and reagents used in the examples, unless otherwise specified, are commercially available.
[0047] The following examples further illustrate the present invention, but do not constitute a limitation thereof. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the invention.
[0048] Example 1 I. Design and Synthesis of Novel Photoaffinity Isoprene Probes Isopentenylation of proteins is an important post-translational modification, playing a crucial role in promoting protein membrane localization, regulating signal transduction, and cell growth and division. While many isopentenylated proteins have been identified, research on their interacting proteins remains limited. This study developed a novel photoaffinity isopentenyl probe by introducing photoreactive groups and alkynyl groups at the carbon terminus of the isopentenyl group. This probe can act as an isoprene analogue to modify proteins. Under UV irradiation, the modified protein covalently cross-links with proteins that recognize the modification, allowing for the analysis of isopentenylated proteins and their interacting proteins within cells.
[0049] 1.1 Experimental Reagents Geraniol (GOH, Maclean), Farnesol (FOH, Bid Pharmaceutical), Pyridine p-toluenesulfonate (PPTS, Xianding), 3,4-dihydropyran (Dibai), Anhydrous dichloromethane (DCM, Adamas), Methyl tert-butyl ether (MTBE, Sinopharm), Sodium chloride (NaCl, Da Mao), Sodium bicarbonate (NaHCO3, Aladdin), Selenium dioxide (SeO2, Maclean), Salicylic acid (Sinopharm), Tert-butyl hydroperoxide (t-BuOOH, Zesheng), Sodium borohydride (NaBH4, Da Mao), Potassium permanganate (Tieta), N-bromosuccinimide (NBS, Dibai), Dimethyl sulfide (CH3S) CH3 (Annaiji), Ethyl acetoacetate (EAA, Bide Pharmaceutical), Lithium diisopropylaminoacetonate (LDA, Yanfeng), 3-bromo-1-(trimethylsilyl)-1-propyne (Dibai), Anhydrous tetrahydrofuran (THF, Adamas), Sodium hydride (NaH, Annaiji), Methanol (Fuyu), Potassium hydroxide (KOH, Guoyao), Concentrated hydrochloric acid (Tieta), 100-200 mesh silica gel (Aladdin), Anhydrous ethanol (Guoyao), Anhydrous methanol (Guoyao), Ammonia methanol (Annaiji), Hydroxylamine-O-sulfonic acid (NH2SO3H, Adamas), Anhydrous triethylamine (TEA, Mairuida), Iodine (I2, Aladdin).
[0050] 1.2 Experimental Apparatus Pipettes (Thermo Fisher), thermostatic magnetic stirrer (IKA), LTQ Orbitrap Velos Pro high-resolution mass spectrometer (Thermo Fisher), UV spectrophotometer (Shimadzu UV-2600), thermostatic metal bath (Mini H-100), nuclear magnetic resonance spectrometer (Brook), direct-drive rotary vane vacuum pump (Wanpeng Electromechanical), three-in-one UV analyzer (Lichen Technology ZF-1), rotary evaporator (RE-2000 A), low-temperature reaction bath (Zhengzhou Great Wall DHJK-8002), electric heating drying oven (Zhongyi Guoke), thin-layer chromatography silica gel plates (Qingdao Huanghai).
[0051] 1.3 Experimental Procedure The synthesis and purification of photoaffinity geraniol probe (GOHP) and farnesol probe (FOHP) are shown below:
[0052] Compound 1a: 9.1 g geraniol (59 mmol, 1.0 equivalence) was dissolved in 15 mL anhydrous dichloromethane. The solution was added to a 100 mL round-bottom flask, and 1.63 g pyridine p-toluenesulfonate (6.49 mmol, 0.11 equivalence) and 21.81 g 3,4-dihydropyran (259.2 mmol, 4.39 equivalence) were added. The mixture was stirred at room temperature for at least 12 hours. The solvent was removed by rotary evaporation. The product was dissolved in methyl tert-butyl ether, washed twice with saturated sodium bicarbonate solution, washed once with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and rotary evaporated to obtain a yellow oily crude product. Purification was achieved by gradient elution using silica gel column chromatography to give a colorless, transparent oily liquid (13.11 g, 93%). Thin-layer chromatography was performed (petroleum ether / ethyl acetate, 9:1, v / v). f = 0.65, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 5.39–5.33 (t, J = 6.0 Hz, 1H), 5.13–5.06 (t, J = 6.0 Hz,1H), 4.65–4.60 (m, 1H), 4.23 (dd, J = 12.0, 6.4 Hz, 1H), 4.03 (dd, J = 11.9, 7.4Hz, 1H), 3.90 (ddd, J = 11.2, 7.7, 3.3 Hz, 4H), 3.53–3.48 (m, 1H), 2.12–2.02(m, 4H), 1.89–1.69 (m, 3H), 1.68 (s, 3H), 1.60 (s, 3H), 1.56–1.50 (m, 3H).
[0053] Compound 2a: 12.01 g of compound 1a (50.8 mmol, 1.0 equivalent) was dissolved in 60 mL of anhydrous dichloromethane. The solution was transferred to a 250 mL round-bottom flask and stirred at 0°C. 0.56 g of selenium dioxide (5.05 mmol, 0.1 equivalent) and 0.70 g of salicylic acid (5.07 mmol, 0.1 equivalent) were added, followed by dropwise addition of 27.44 mL of a decane solution of tert-butyl hydroperoxide (5.5 mol / L, 150.92 mmol, 3.0 equivalent). After reacting for 15 minutes, the solution was placed at room temperature (25°C) and stirred for at least 12 hours. The solvent was removed by rotary evaporation. The residue was added to water and extracted three times with an equal volume of methyl tert-butyl ether, washed twice with sodium bicarbonate solution, dried over anhydrous sodium sulfate, filtered, and rotary evaporated to obtain a yellow, oily crude product. The crude product was dissolved in 60 mL of ethanol, and 0.572 g of sodium borohydride (15.1 mmol, 0.3 equivalence) was added at 0 °C. The reaction was allowed to proceed for 1 hour, and the product was observed on a TLC plate until the byproducts visible under UV light completely disappeared. The reaction was quenched with ice water, extracted three times with methyl tert-butyl ether, washed twice with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and then rotary evaporated to obtain a yellow oily crude product. Purification was achieved using silica gel column chromatography with gradient elution to give a colorless, transparent oily liquid (4.896 g, 38%). Thin-layer chromatography (petroleum ether / ethyl acetate, 7:3, v / v) was performed. f = 0.53, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 5.37 (dtd, J = 12.6, 6.6, 1.4 Hz, 2H), 4.65–4.60 (m, 1H), 4.24 (dd, J = 11.7, 6.2 Hz, 1H), 4.02 (dd, J = 11.9, 7.4 Hz, 1H), 3.99 (s, 2H), 3.89 (ddd, J = 11.2, 7.8, 3.3 Hz, 1H), 3.55–3.48 (m, 1H), 2.21–2.05 (m, 4H), 1.87–1.71 (m, 3H), 1.68 (s, 3H), 1.66 (s, 3H), 1.62–1.56 (m,3H).
[0054] Compound 3a: In a 100 mL round-bottom flask, 2.40 g of N-bromosuccinimide (13.5 mmol, 1.2 equivalents) was dissolved in 20 mL of anhydrous dichloromethane. The flask was cooled to -35 °C, and 1.21 mL of dimethyl sulfide (16.88 mol, 1.5 equivalents) was added dropwise. The reaction was allowed to proceed for 1 hour, then transferred to an ice bath for 15 minutes. The flask was then cooled back to -35 °C, at which point the reaction solution was opaque and milky yellow. 2.86 g of compound 2a (11.25 mmol, 1.0 equivalents) dissolved in 10 mL of anhydrous dichloromethane was added, and the reaction was allowed to proceed for 10 minutes. The flask was then transferred to room temperature (25 °C) and reacted in the dark for 4 hours, at which point the reaction solution turned transparent yellow. The reaction was quenched with saturated sodium bicarbonate, extracted three times with ethyl acetate, dried over anhydrous sodium sulfate, filtered, and then rotary evaporated to obtain a brownish-red oily crude product. Purification was performed using a short silica gel column, followed by elution with petroleum ether:ethyl acetate = 50:1, yielding a yellow oily liquid (3.05 g, 85%), which was directly used in the synthesis of compound 5a. 1 H NMR (400 MHz, CDCl3): δ 5.58 (t, J = 6.7 Hz, 1H), 5.39–5.33 (t, J = 6.7 Hz,1H), 4.65–4.59 (m, 1H), 4.24 (dd, J = 11.9, 6.3 Hz, 1H), 4.02 (dd, J = 12.1, 7.3Hz, 1H), 3.96 (s, 2H), 3.89 (ddd, J = 11.2, 7.5, 3.7 Hz, 1H), 3.51 (dt, J = 11.1,5.3 Hz, 1H), 2.22–2.02 (m, 4H), 1.86–1.77 (m, 3H), 1.75 (s, 3H), 1.67 (s,3H), 1.63–1.58 (m, 3H).
[0055] Compound 4: A magnetic stir bar was added to a 100 mL round-bottom flask, which was then evacuated and protected with nitrogen. The flask was cooled to -78 °C. 3.01 mL of ethyl acetoacetate (23.8 mmol, 1.0 equivalence) was dissolved in 20 mL of anhydrous tetrahydrofuran and added to the reaction flask. 35.7 mL of a solution of lithium diisopropylaminotetrahydrofuran / hexane (12:25) (2 mol / L, 71.4 mmol, 3.0 equivalence) was slowly added dropwise to the reaction flask. The mixture was reacted at -78 °C for 1 hour, then transferred to an ice bath and reacted for 30 minutes, followed by cooling at -78 °C for 15 minutes. 4.97 g of 3-bromo-1-(trimethylsilyl)-1-propyne (26.0 mmol, 1.1 equivalence) in 20 mL of anhydrous tetrahydrofuran was added, and the mixture was reacted for 1 hour, then transferred to an ice bath and reacted for 30 minutes. The reaction was quenched by adding glacial acetic acid with the mixture under open stirring. Add 50 mL of water and extract the aqueous layer three times with MTBE, wash twice with saturated sodium bicarbonate solution, wash once with saturated sodium chloride solution, dry to anhydrous sodium sulfate, filter, and remove the solvent by rotary evaporation to obtain a dark reddish-brown oily crude product. Purify by gradient elution using silica gel column chromatography to give a yellow oily liquid (4.53 g, 75%). Develop by thin-layer chromatography (petroleum ether / ethyl acetate, 4:1, v / v), R f =0.46, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 4.20 (q, J = 7.2 Hz, 1H), 3.46 (s,1H), 2.81–2.77 (m, 1H), 2.53–2.47 (m, 1H), 1.28 (t, J = 7.2 Hz, 2H), 0.14 (s, 4H).
[0056] Compound 5a: A magnetic stir bar was added to a 100 mL double-necked flask. 10 mL of 0.396 g of NaH dissolved in anhydrous tetrahydrofuran (60% purity, 9.9 mmol, 1.1 equivalence) was added with the flask open. The mixture was stirred in an ice bath, and 2.29 g of compound 4 (9.0 mmol, 1.0 equivalence) in 15 mL of anhydrous tetrahydrofuran solution was added dropwise. Gas generation was observed, and the mixture was stirred for 15 minutes. After the gas was completely released, 3.00 g of freshly prepared compound 3a (9.45 mmol, 1.0 equivalence) in 15 mL of anhydrous tetrahydrofuran solution was added. The reaction was allowed to proceed for 15 minutes, then transferred to reflux at 70 °C for at least 16 hours until compound 4 completely disappeared from the thin-layer chromatography. The reaction mixture was cooled to room temperature, and 9 mL of methanol and 18 mL of KOH aqueous solution (3 mol / L) were added. The mixture was then refluxed at 70 °C for approximately 6–16 hours until the intermediate product was observed to have completely disappeared on thin-layer chromatography. The base was neutralized with 54 mL of HCl aqueous solution (1 mol / L), extracted three times with methyl tert-butyl ether, washed twice with saturated sodium bicarbonate solution, washed once with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and the solvent was removed by rotary evaporation to obtain a brownish-red oily crude product. Purification was performed using silica gel column chromatography with gradient elution to give a yellow oily liquid (1.93 g, 64%). Thin-layer chromatography (petroleum ether / ethyl acetate, 8:1, v / v) was performed. f = 0.40, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 5.34 (t, J = 7.0 Hz, 1H), 5.10 (t, J = 7.0Hz, 1H), 4.61 (t, J = 3.8 Hz, 1H), 4.22 (dd, J = 12.0, 6.4 Hz, 1H), 4.01 (dd, J =11.9, 7.4 Hz, 1H), 3.88 (ddd, J = 11.3, 7.9, 3.0 Hz, 1H), 3.53–3.45 (m, 1H), 2.65 (t, J = 7.3 Hz, 2H), 2.50 (t, J = 7.7 Hz, 2H), 2.43 (td, J = 7.4, 2.7 Hz, 2H), 2.25 (t, J = 7.8 Hz, 2H), 2.13–1.99 (m, 4H), 1.70 (ddd, J= 12.8, 9.5, 3.6 Hz,3H), 1.66 (s, 3H), 1.59 (s, 3H), 1.55–1.47 (m, 3H); 13 C NMR (151 MHz, CDCl3): δ 208.25, 139.91, 133.88, 124.86, 121.08, 98.01, 83.30, 68.77, 63.81, 62.42,41.66, 41.48, 39.57, 33.57, 30.90, 26.39, 19.79, 16.53, 16.19, 13.10; HRMS, found 350.2697 (C 21 H 36 NO3 + [M+NH4] + , requires 350.2690); 355.2267 (C 21 H 32 NaO3 + [M+Na] + , requires 355.2244); 371.1988 (C 21 H 32 KO3 + [M+K] + (requires 371.1984).
[0057] Compound 6a: 0.86 g of compound 5 (2.6 mmol, 1.0 equivalent) was dissolved in 20 mL of anhydrous ethanol. The solution was added to a 50 mL round-bottom flask, and 65.30 mg of pyridine p-toluenesulfonate (0.26 mmol, 0.1 equivalent) was added. The mixture was stirred at 60 °C for 4 hours, and the solvent was removed by rotary evaporation to obtain a yellow, oily crude product. Purification was achieved by gradient elution using silica gel column chromatography to give a pale yellow, oily liquid (0.359 g, 56%). Thin-layer chromatography (petroleum ether / ethyl acetate, 4:1, v / v) was performed. f = 0.30, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 5.42–5.36 (m, 1H), 5.13–5.07 (m, 1H), 4.15 (d, J = 6.9 Hz, 2H), 2.66 (dd, J = 8.1, 6.5 Hz, 2H), 2.52 (t, J= 7.6 Hz, 2H), 2.44(td, J = 7.4, 2.7 Hz, 2H), 2.30–2.24 (m, 2H), 2.14–2.00 (m, 4H), 1.95 (t, J = 2.7Hz, 1H), 1.67 (s, 3H), 1.60 (s, 3H); 13 C NMR (151 MHz, CDCl3): δ 208.42, 139.27,133.87, 124.73, 123.89, 83.28, 68.79, 59.47, 41.54, 41.41, 39.42, 33.52,26.24, 16.31, 16.18, 13.09; HRMS, found 249.1852 (C 16 H 25 O2 + [M+H] + , requires249.1850); 266.2115 (C 16 H 28 NO2 + [M+NH4] + , requires 266.2115); 271.1667(C 16 H 24 NaO2 + , [M+Na] + , requires 271.1669); 287.1415 (C 16 H 24 KO2 + [M+K] + (requires 287.1408).
[0058] Photoaffinity geraniol probe (GOHP, compound 7a): A magnetic stir bar was added to a 50 mL round-bottom flask, which was then evacuated and protected with nitrogen, and cooled to -78 °C. 0.245 g of compound 6 (1 mmol, 1.0 equivalent) was dissolved in a small amount of anhydrous methanol and added to the reaction flask. Then, 5.14 mL of ammonia-methanol solution (7 mol / L, 36 mmol, 36.0 equivalent) was slowly added dropwise. After stirring for 10 minutes, the mixture was placed at 37 °C and stirred in the dark for at least 5 hours. It was then cooled again to -78 °C. 0.8 mL of anhydrous methanol solution containing 0.13 g of hydroxylamine-O-sulfonic acid (1.15 mmol, 1.15 equivalent) was added, and the mixture was kept at -78 °C for 0.5 hours. Then, it was stirred at 37 °C for at least 1 hour, followed by stirring overnight at room temperature (25 °C). A white precipitate formed. The precipitate was filtered, the residue was washed with methanol, and the filtrate was concentrated under reduced pressure and dissolved in 1 mL of anhydrous dichloromethane. Add 0.1733 mL of anhydrous TEA (1.25 mmol, 1.25 equivalents) at 0 °C, then add 10 mL of a saturated dichloromethane solution of I₂ and stir until a persistent orange-brown color (which does not fade) appears. After maintaining this state for 1 hour, evaporate the dichloromethane to obtain the crude product, which is stored at 4 °C protected from light. Purify by gradient elution using silica gel column chromatography to give a pale yellow oily liquid (63.1 mg, 24%). Develop by thin-layer chromatography (petroleum ether / ethyl acetate, 2:1, v / v), R f = 0.62, potassium permanganate color development. 1 HNMR (600 MHz, CDCl3): δ 5.41 (t, J = 6.9 Hz, 1H), 5.12 (t, J = 6.8 Hz, 1H), 4.15(d, J = 7.0 Hz, 2H), 2.15–2.02 (m, 4H), 2.02–1.95 (m, 2H), 1.79 (dd, J = 9.7, 6.5Hz, 2H), 1.68 (s, 3H), 1.62 (t, J = 7.4 Hz, 2H), 1.55 (s, 3H), 1.54–1.46 (m,2H); 13 C NMR (151 MHz, CDCl3): δ 139.67, 133.82, 124.96, 123.70, 83.03, 69.17,59.56, 39.46, 33.60, 32.50, 31.57, 28.33, 26.37, 16.41, 16.07, 13.47; HRMS, found 278.2330 (C 16 H 28N3O + [M+NH4] + , requires 278.2227); 299.1523 (C 16 H 24 KN2O + [M+K] + (requires 299.1521).
[0059] Compound 1b: 11.11 g of geraniol (50 mmol, 1.0 equivalence) was dissolved in 15 mL of anhydrous dichloromethane. The solution was added to a 100 mL round-bottom flask, and 1.255 g (5.0 mmol, 0.1 equivalence) of pyridine p-toluenesulfonate and 16.83 g of 3,4-dihydropyran (200 mmol, 4.0 equivalence) were added. The mixture was stirred at room temperature (28 °C) for at least 12 hours. The solvent was removed by rotary evaporation. The solution was dissolved in methyl tert-butyl ether, washed twice with saturated sodium bicarbonate solution, washed once with saturated sodium chloride solution, dried over anhydrous sodium sulfate, and filtered. Rotary evaporation yielded a yellow oily crude product. Purification was performed using silica gel column chromatography with gradient elution to give a colorless, transparent oily liquid (13.94 g, 91%). Thin-layer chromatography was performed (petroleum ether / ethyl acetate, 9:1, v / v). f = 0.72, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3) δ 5.36 (t, J = 7.2 Hz, 1H), 5.09 (dt, J = 13.3, 7.0Hz, 2H), 4.62 (t, J = 3.7 Hz, 1H), 4.23 (dd, J = 12.0, 6.4 Hz, 1H), 4.05 – 3.99(m, 1H), 3.89 (ddd, J = 11.1, 7.7, 2.9 Hz, 1H), 3.53 – 3.50 (m, 1H), 2.15 –1.99 (m, 8H), 1.88 – 1.70 (m, 3H), 1.67 (d, J = 3.7 Hz, 6H), 1.59 (s, 6H), 1.52(qd, J = 10.3, 6.8 Hz, 3H).
[0060] Compound 2b: 13.46 g of compound 1b (13.9 mmol, 1.0 equivalence) was dissolved in 40 mL of anhydrous dichloromethane. The solution was transferred to a 250 mL round-bottom flask and stirred at 0°C. 0.487 g of selenium dioxide (4.39 mmol, 0.1 equivalence) and 0.606 g of salicylic acid (1.39 mmol, 0.1 equivalence) were added, followed by dropwise addition of 14 mL of a decane solution of tert-butyl hydroperoxide (5.5 mol / L, 77.3 mmol, 1.75 equivalence). After reacting for 15 minutes, the solution was placed at room temperature (25°C) and stirred for at least 12 hours. The solvent was removed by rotary evaporation. The residue was added to water and extracted three times with an equal volume of methyl tert-butyl ether, washed twice with sodium bicarbonate solution, dried over anhydrous sodium sulfate, filtered, and rotary evaporated to obtain a yellow, oily crude product. The crude product was dissolved in 40 mL of ethanol, and 0.498 g of sodium borohydride (13.17 mmol, 0.3 equivalent) was added at 0 °C. The reaction was allowed to proceed for 1 hour, and the product was observed on a TLC plate until the byproducts visible under UV light completely disappeared. The reaction was quenched with ice water, extracted three times with methyl tert-butyl ether, washed twice with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and then rotary evaporated to obtain a yellow oily crude product. Purification was achieved using silica gel column chromatography with gradient elution to give a pale yellow oily liquid (2.14 g, 17%). Thin-layer chromatography (petroleum ether / ethyl acetate, 4:1, v / v) was performed. f = 0.3, potassium permanganate color development. 1 H NMR (400 MHz, CDCl3) δ 5.57 – 5.16 (m, 2H), 5.15 – 5.05 (m, 1H), 4.62(dd, J = 4.5, 2.8 Hz, 1H), 4.23 (dd, J = 11.9, 6.3 Hz, 1H), 4.08 – 4.02 (m, 1H), 4.01 – 3.92 (m, 2H), 3.89 (td, J = 8.0, 4.0 Hz, 1H), 3.54 – 3.47 (m, 1H), 2.17 – 1.98 (m, 8H), 1.89 – 1.72 (m, 3H), 1.67 (d, J = 5.0 Hz, 6H), 1.60 (s, 3H), 1.57 – 1.51 (m, 3H).
[0061] Compound 3b: In a 100 mL round-bottom flask, 1.28 g of N-bromosuccinimide (7.2 mmol, 1.2 equivalence) was dissolved in 10 mL of anhydrous dichloromethane. The flask was cooled to -35 °C, and 0.65 mL (9.0 mol, 1.5 equivalence) of dimethyl sulfide was added dropwise. The reaction was allowed to proceed for 1 hour, then transferred to an ice bath for 15 minutes. The flask was then cooled back to -35 °C, at which point the reaction solution was opaque and milky yellow. 1.94 g of compound 2b (6.0 mmol, 1.0 equivalence) dissolved in 10 mL of anhydrous dichloromethane was added, and the reaction was allowed to proceed for 10 minutes. The flask was then transferred to room temperature (25 °C) and reacted in the dark for 4 hours, at which point the reaction solution became transparent yellow. The reaction was quenched with saturated sodium bicarbonate, extracted three times with ethyl acetate, dried over anhydrous sodium sulfate, filtered, and then rotary evaporated to obtain a brownish-red oily crude product. Purification was performed using a short silica gel column, eluted with petroleum ether:ethyl acetate = 50:1, to give a yellow oily liquid, which was directly used in the synthesis of compound 5b.
[0062] Compound 5b: 0.264 g of sodium hydride (6.6 mmol, 1.1 equivalence, 60%) was dissolved in 7.5 mL of anhydrous THF and added to a 250 mL double-necked flask. The mixture was stirred in an ice bath, and 1.53 g of compound 4 (6.0 mmol, 1.0 equivalence) in 7.5 mL of anhydrous THF solution was added dropwise. Gas generation was observed, and the mixture was stirred for 15 minutes. After the gas was completely released, 15 mL of freshly prepared anhydrous THF solution of compound 3b was added, and the reaction was allowed to proceed for 15 minutes. The mixture was then transferred to reflux at 70 °C for at least 16 hours until compound 4 completely disappeared from the thin-layer chromatography. The reaction mixture was cooled to room temperature, and 6 mL of methanol and 12 mL of KOH aqueous solution (3 mol / L) were added. The mixture was then refluxed at 70 °C for approximately 6–16 hours until the intermediate product was observed to have completely disappeared on thin-layer chromatography. The base was neutralized with 36 mL of HCl aqueous solution (1 mol / L), extracted three times with methyl tert-butyl ether, washed twice with saturated sodium bicarbonate solution, washed once with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and the solvent was removed by rotary evaporation to obtain a brownish-red oily crude product. Purification was performed using silica gel column chromatography with gradient elution to give a yellow oily liquid (1.15 g, 48%). Thin-layer chromatography (petroleum ether / ethyl acetate, 8:1, v / v) was performed. f = 0.39, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3) δ 5.36 (ddt, J = 6.1, 4.6, 1.4 Hz, 1H), 5.16 – 5.01 (m, 2H), 4.62 (dd, J = 4.5, 3.0 Hz, 1H), 4.27 – 4.21 (m, 1H), 4.03 (dd, J= 11.9, 7.4 Hz, 1H), 3.89 (ddd, J = 11.3, 8.0,2.8 Hz, 1H), 3.53 – 3.49 (m, 1H), 2.69 – 2.63 (m, 2H), 2.52 (td, J = 7.8, 5.1Hz, 2H), 2.44 (dddd, J = 8.3, 7.0, 2.7, 1.2 Hz, 2H), 2.26 (dq, J = 9.6, 3.2 Hz,2H), 2.13 – 1.96 (m, 8H), 1.94 (t, J = 2.7 Hz, 1H), 1.85 – 1.70 (m, 3H), 1.67(dd, J = 3.4, 2.2 Hz, 4H), 1.62 – 1.57 (m, 6H), 1.56 – 1.48 (m, 3H); 13 C NMR (126MHz, CDCl3) δ 208.42, 142.94, 133.50, 125.01, 124.17, 124.13, 120.87, 97.91,83.28, 69.07, 63.76, 62.41, 41.64, 41.57, 39.64, 33.55, 30.85, 26.41, 26.26,25.83, 25.63, 23.49, 19.75, 16.56, 16.17, 13.04; HRMS, found 423.2878(C 16 H 24 NaN2O + , [M+Na] + (requires 423.2870).
[0063] Compound 6b: 0.276 g of compound 5b (0.69 mmol, 1.0 equivalent) was dissolved in 7 mL of anhydrous ethanol. The solution was added to a 50 mL round-bottom flask, and 17.9 mg of pyridine p-toluenesulfonate (0.07 mmol, 0.1 equivalent) was added. The mixture was stirred at 60 °C for 4 hours, and the solvent was removed by rotary evaporation to obtain a yellow, oily crude product. Purification was achieved by gradient elution using silica gel column chromatography to give a pale yellow, oily liquid (58.6 mg, 27%). Thin-layer chromatography was performed (petroleum ether / ethyl acetate, 4:1, v / v). f = 0.30, potassium permanganate color development.1 H NMR (600 MHz, CDCl3) δ 5.41 (ddt, J = 6.9, 5.6, 1.3 Hz, 1H), 5.22 –5.01 (m, 2H), 4.15 (d, J = 6.8 Hz, 2H), 2.66 (td, J = 7.3, 1.6 Hz, 2H), 2.51 (td, J = 7.7, 4.6 Hz, 2H), 2.44 (dddd, J = 8.1, 7.0, 2.7, 1.0 Hz, 2H), 2.26 (td, J =8.0, 3.8 Hz, 2H), 2.14 – 1.97 (m, 8H), 1.94 (dd, J = 3.0, 2.2 Hz, 1H), 1.67 (q, J = 1.4 Hz, 3H), 1.61 (d, J = 1.3 Hz, 3H), 1.59 (d, J = 1.6 Hz, 3H); 13 C NMR (126MHz, CDCl3) δ 208.36, 139.60, 131.87, 124.99, 124.90, 124.73, 123.44, 83.18,60.40, 59.38, 41.52, 41.45, 39.79, 33.46, 26.52, 26.44, 26.27, 26.19, 23.36,21.05, 12.95; HRMS, found 339.2296 (C 16 H 24 NaN2O + , [M+Na] + (requires 339.2295).
[0064] Photoaffinity geraniol probe (FOHP, compound 7b): A magnetic stir bar was added to a 50 mL round-bottom flask, which was then evacuated and protected with nitrogen, and cooled to -78 °C. 0.044 g of compound 6b (0.14 mmol, 1.0 equivalent) was dissolved in a small amount of anhydrous methanol and added to the reaction flask. Then, 0.71 mL of ammonia-methanol (5.0 mmol, 36.0 equivalent, 7 mol / L) was slowly added dropwise. After stirring for 10 minutes, the mixture was placed at 37 °C and stirred in the dark for at least 5 hours. It was then cooled again to -78 °C. A 0.0182 g (0.161 mmol, 1.15 equivalent) solution of hydroxylamine-O-sulfonic acid in 0.25 mL of anhydrous methanol was added, and the mixture was kept at -78 °C for 0.5 hours. Then, it was stirred at 37 °C for at least 1 hour, followed by direct stirring at room temperature (25 °C) without opening the container overnight, resulting in the formation of a white precipitate. The precipitate was filtered, the residue was washed with methanol, and the filtrate was concentrated under reduced pressure and dissolved in 1.0 mL of anhydrous DCM. Add 0.0195 mL (0.175 mmol, 1.25 equivalence) of anhydrous TEA at 0 °C, followed by 10 mL of saturated DCM solution of I2. Stir until a persistent orange-brown color (which does not fade) appears. After maintaining this state for 1 hour, evaporate the DCM to obtain the crude product, which is stored at 4 °C protected from light. Purify using silica gel column chromatography with gradient elution to give a pale yellow oily liquid (9.7 mg, 21%). Develop with thin-layer chromatography (petroleum ether / ethyl acetate, 2:1, v / v). R f = 0.68, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3) δ 5.38 – 5.32 (m, 1H), 5.12 (d, J = 8.9 Hz, 2H), 4.16(d, J = 6.9 Hz, 2H), 2.06 – 1.93 (m, 11H), 1.78 (d, J = 8.5 Hz, 2H), 1.68 (d, J =3.7 Hz, 6H), 1.63 – 1.62 (m, 2H), 1.60 (d, J = 5.0 Hz, 3H), 1.55 (d, J = 7.5 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 139.65, 133.50, 125.18, 124.70, 123.94, 123.41,82.88, 69.06, 59.41, 39.80, 39.55, 39.48, 33.49,28.23, 26.55, 26.47, 26.30,26.19, 23.37, 19.20, 13.34; HRMS, found 351.2421 (C 16 H 24 NaN2O + , [M+Na] + , requires 339.2407).
[0065] 1.4 Results and Discussion In the human body, the hydroxyl group of farnesol undergoes pyrophosphorylation and covalently binds to the thiol group on the cysteine residue in the C-terminal CAAX sequence of proteins to form a thioether bond. Therefore, by introducing photoreactive groups and bioorthogonal groups at the C-terminus of geraniol, photoaffinity geraniol probes and farnesol probes are obtained. Figure 1 The modified protein is made similar in length to farnesol or geraniol, allowing for similar protein modifications within cells. Then, the modified protein and its interacting protein are covalently cross-linked under 365 nm UV light using the photoreactive group diacylpropidine. These proteins are then fluorescently labeled with bioorthogonal groups for fluorescent gel imaging or cell imaging; or biotinylated and enriched using streptavidin agar beads followed by mass spectrometry detection to study intracellular isopentenylated proteins and their interacting proteins. Figure 2 Since the two probes have similar structures and functions, the following discussion will mainly focus on demonstrating the function and application of this type of probe through the photoaffinity geraniol probe (GOHP).
[0066] II. Geraniol probe labeling and protein fluorescence gel imaging analysis of HEK 293T cells First, the labeling of proteins in living cells by the photoaffinity geraniol probe was analyzed using fluorescent gel imaging. Since the probe can isoprenoidize proteins, under non-UV conditions, the modified proteins are primarily labeled. After linking to fluorophores via click-through chemistry, the proteins are separated by polyacrylamide gel electrophoresis for fluorescent gel imaging analysis. Under 365 nm UV irradiation, the photoreactive groups can covalently cross-link with interacting proteins of the modified protein, thus linking the two proteins. This should be observed as an increase in the molecular weight of the labeled band in the fluorescent gel imaging. Furthermore, under UV irradiation, proteins that are not covalently bound to the probe can also be labeled, aiding in the discovery of novel proteins in the isoprenoid pathway.
[0067] 2.1 Experimental Reagents Methanol (Fuyu), glacial acetic acid (Fuyu), farnesol (FOH, Bide Pharmaceuticals), lovastatin (McLean), sodium chloride (Titan), chloroform (Titan), 4-hydroxyethylpiperazine ethanesulfonic acid (HEPES, Genview) t - Octylphenoxypolyethoxyethanol (Triton X-100, Beyotime), Tris(2-carboxyethyl)phosphonic acid hydrochloride (TCEP, Biotech), 2-(4-((bis(1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic acid (BTTAA, Biotech), Copper sulfate (Biotech), Dodecyl sulfate (SDS, Genview), 30% Acrylamide (Dingguo), Bromophenol blue (Biotech), Coomassie Brilliant Blue R-250 (Solepro), Protein Marker (Thermo Fisher), β-mercaptoethanol (Biotech), Tris(hydroxymethyl)aminomethane hydrochloride (Tris, Solepro), Protease inhibitor (Aimer), BCA kit (Beyotime), DMEM (Thermo Fisher), Fetal bovine serum (FBS, ExCell Bio), Penicillin-streptomycin (PS, Thermo Fisher) Fisher), 1× phosphate buffer (1×PBS, pH = 7.4, Thermo Fisher), dimethyl sulfoxide (DMSO, Sigma), RIPA lysis buffer (Beyotime), HEPES buffer (50 mmol / L HEPES, 150 mmol / L sodium chloride, pH = 7.4).
[0068] 2.2 Experimental Apparatus Pipettes (Thermo Fisher), centrifuges (Eppendorf), thermostatic metal bath (Mini H-100), microplate reader (Bio-Rad), electrophoresis apparatus (Bio-Rad), 365 nm UV lamp (ZF-1), vortex apparatus (IKA), AI800 multispectral imager (GE), clean bench (Shandong Boke), incubator (Thermo Fisher).
[0069] 2.3 Experimental Procedure HEK293T cells were cultured in DMEM medium (containing 10% fetal bovine serum and 1% penicillin-streptomycin) at 37°C and 5% CO2 until the cell density reached 70%, at which point the drug was administered. Each well was added to medium containing 10 μmol / L of the probe and incubated for 24 hours. For the lovastatin group, each well was incubated with medium containing 10 μmol / L lovastatin for 6 hours, then replaced with medium containing both the probe and lovastatin for 24 hours. The competition group was incubated with 100 μmol / L farnesol and the probe, while the control group was incubated with medium containing the same DMSO concentration. After incubation, the medium was removed, the cells were washed three times with 1×PBS, placed on ice, irradiated with a 365 nm UV lamp for 10 minutes, and then collected by centrifugation after being removed from the culture dish. Cells were lysed on ice for 30 minutes with RIPA lysis buffer (containing 1% protease inhibitor) and centrifuged at 1000 rpm for 30 minutes at 4°C. Protein concentration in the supernatant was determined using a BCA kit. 100 μg of protein was taken, and HEPES buffer containing 0.1% Triton X-100 was added to bring the final protein concentration to 1 mg / mL. Then, TCEP, BTTAA, copper sulfate, and Rhodamine B-PEG3-azide (RB-N3) were added to bring the final concentrations to 1 mmol / L, 100 μmol / L, 1 mmol / L, and 100 μmol / L, respectively. The mixture was vortexed at room temperature for 3 hours. Ten volumes of methanol were added, and the mixture was incubated overnight at -20°C. The precipitate was centrifuged at 10,000 rpm, and the protein precipitate was retained. The precipitate was dissolved in buffer containing 4% SDS and the protein concentration was measured. The protein solution was added to 4× loading buffer, heated at 95°C for 5 minutes, and subjected to polyacrylamide gel electrophoresis. Fluorescent gel imaging was performed on an AI800 imager.
[0070] 2.4 Results and Discussion Since farnesyl pyrophosphate synthesized by the cell itself acts as a competitive agent to inhibit the isoprenylation modification of proteins by the probe, lovastatin can be added to the experiment to block the synthesis of isoprenoid compounds by inhibiting HMG-CoA reductase, thereby improving the labeling efficiency of the probe. Fluorescent gel imaging results show that lovastatin can significantly increase the labeling effect of the probe on specific bands, while the labeling of some proteins remains unaffected. Figure 4 Under ultraviolet irradiation, new bands appeared, including some with relatively larger molecular weights, verifying the feasibility of the design. Furthermore, the addition of farnesol significantly inhibited probe labeling, indicating that the probe could effectively label proteins interacting with farnesol, demonstrating good labeling specificity.
[0071] III. Geraniol probe labeling and proteomic analysis of HEK293T cells After confirming the expected labeling of the photoaffinity geraniol probe using fluorescent gel imaging, further analysis of the probe-labeled proteins was conducted using mass spectrometry-based proteomics. Following probe labeling of live cells, cell lysates were extracted, and biotin was introduced via click chemistry. The labeled proteins were then enriched using streptavidin beads and analyzed by mass spectrometry. Differences in probe labeling under conditions of lovastatin addition and without UV exposure were analyzed using label-free quantitative proteomics.
[0072] 3.1 Experimental Reagents Lovastatin (Maclean), Formic Acid (FA, Thermo Fisher), Acetonitrile (ACN, Thermo Fisher), Glacial Acetic Acid (Fuyu), Ammonium Bicarbonate (Bide Pharmaceuticals), 2-Iodoacetamide (IAA, Bide Pharmaceuticals), Urea (Genview), Biotin-DADPS-Azide (Leyan), Methanol (Fuyu), Protein Marker (Thermo Fisher), Sodium Chloride (Titan), Chloroform (Titan), 4-Hydroxyethylpiperazine Ethyl Acetate (HEPES, Genview) t- Octylphenoxypolyethoxyethanol (Triton X-100, Beyotime), Tris(2-carboxyethyl)phosphonic acid hydrochloride (TCEP, Biotech), 2-(4-((bis(1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic acid (BTTAA, Biotech), Copper sulfate (Bitatech), Sodium dodecyl sulfate (SDS, Genview), 30% acrylamide (Dingguo), Bromophenol blue (Bitatech), Coomassie Brilliant Blue R-250 (Solepro), β-mercaptoethanol (Bitatech), Tris(hydroxymethyl)aminomethane hydrochloride (Tris•HCl, Solepro), Protease inhibitor (Aimer), BCA kit (Beyotime), DMEM medium (Thermo Fisher), Fetal bovine serum (FBS, ExCell Bio), Penicillin-streptomycin (PS, Thermo Fisher) Fisher), 1× phosphate buffer (1×PBS, pH=7.4, ThermoFisher), dimethyl sulfoxide (DMSO, Sigma), RIPA lysis buffer (Beyotime), sodium hydroxide (Sinopharm), streptavidin microbeads (ThermoFisher), and mass spectrometry grade trypsin (ThermoFisher).
[0073] 3.2 Experimental Apparatus Centrifuge (Eppendorf), 365 nm UV lamp (ZF-1), 0.22 μm filter membrane (Agela), constant temperature metal bath (Mini H-100), ultrasonic cleaner (Shandong Boke), C18 Tip (Thermo Fisher), high resolution mass spectrometer (Orbitrap Exploris 480), ultra-high performance liquid chromatography system (Vanquish Neo UHPLC), centrifuge (Eppendorf), microplate reader (Bio-Rad), vortex apparatus (IKA), horizontal shaker (Dalong), electrophoresis apparatus (Bio-Rad), pH meter (Sartorius), rotary shaker (Thermo Fisher).
[0074] 3.3 Experimental Procedure 3.3.1 Preparation of probe-labeled mass spectrometry samples of HEK293T cells by on-Beads enzymatic digestion method HEK293T cells were cultured in DMEM medium (containing 10% fetal bovine serum and 1% penicillin / streptomycin) at 37°C and 5% CO2 until the cell density reached 70%. The cells were then incubated in medium containing 10 μmol / L lovastatin for 6 hours, followed by incubation in medium containing 10 μmol / L probe and 10 μmol / L lovastatin for 24 hours. A control group was incubated in medium containing the same DMSO concentration. After incubation, the medium was removed, and the cells were washed three times with 1×PBS. The culture dishes were placed on ice and irradiated with a 365 nm UV lamp for 5 minutes. After removing the cells from the culture dishes, they were collected by centrifugation. RIPA lysis buffer (containing 1% protease inhibitor) was added, and the cells were lysed on ice for 30 minutes, followed by centrifugation at 1000 rpm for 30 minutes at 4°C. The protein concentration in the supernatant was determined using a BCA kit, and 100 μg was collected for fluorescence gel imaging analysis. Take another 1 mg of protein and add HEPES buffer containing 0.1% Triton X-100 to bring the final protein concentration to 1 mg / mL. Then add TCEP, BTTAA, copper sulfate, and biotin-DADPS-azide to bring the final concentrations to 1 mmol / L, 100 μmol / L, 1 mmol / L, and 100 μmol / L, respectively. Vortex at room temperature for 3 hours. Add 10 volumes of methanol and incubate overnight at -20°C. Centrifuge at 10,000 rpm, retain the protein precipitate, dissolve it in buffer containing 4% SDS, and add HEPES buffer to 1 mL. Wash the streptavidin beads with HEPES buffer and add them to the sample. Incubate on a rotary shaker at room temperature for 3 hours. Transfer the sample to a centrifuge filter column and wash with 1×PBS, 1×PBS, 10×PBS, 1×PBS, and 25 mmol / L ammonium bicarbonate solution containing 1% SDS, respectively. The microbeads were then transferred to centrifuge tubes using a 50 mmol / L ammonium bicarbonate solution containing 8 mol / L urea, and the solution was added to a total volume of 1 mL. TCEP solution was added to a final concentration of 20 mmol / L, and the reaction was carried out at 37°C for 1 hour. IAA was then added to a final concentration of 50 mmol / L, and the reaction was carried out at room temperature (25°C) in the dark for 30 minutes. The supernatant was removed by centrifugation, and the mixture was washed three times with 25 mmol / L ammonium bicarbonate solution. 100 μL of a 25 mmol / L ammonium bicarbonate solution containing 1 μg / μL mass spectrometry-grade trypsin was added, and the mixture was incubated at 37°C for 16 hours. After enzymatic digestion, the supernatant was transferred to a new centrifuge tube, washed three times with 25 mmol / L ammonium bicarbonate solution, and the supernatants were combined, centrifuged, and concentrated to obtain Sample 1.Add 200 μL of 10% formic acid solution to the remaining microbeads, mix on a rotary shaker at room temperature for 30 minutes, centrifuge at 3000 rpm for 2 minutes, transfer the supernatant to a new centrifuge tube, repeat three times, combine the supernatants and incubate at 37°C for 30 minutes. Add 200 μL of 50% acetonitrile to the remaining microbeads and incubate at 37°C for 30 minutes, transfer the supernatant and wash once with 200 μL of 50% acetonitrile, combine the supernatants to obtain sample two. Desalt the sample using C18 Tip, centrifuge and concentrate to obtain the desalted sample. All samples were dissolved in 20 μL of HPLC-grade water, with 4 μL of sample one injected and 8 μL of sample two injected. Each condition was performed in triplicate.
[0075] 3.3.2 LC-MS / MS Detection and Analysis Methods Detection was performed using a Vanquish Neo liquid chromatography-tandem Orbitrap Exploris 480 mass spectrometer. A self-prepared nano-liquid C18 capillary column was used, with a column packing particle size of 3 μm, an inner diameter of 75 μm, and a length of 18 cm. Mobile phase A was water containing 0.1% FA, and mobile phase B was acetonitrile containing 0.1% FA. The flow rate was 300 nL / min, and gradient elution was used to separate peptides. The Orbitrap Exploris 480 was used in positive ion detection mode, with a primary full scan and a secondary scan with a cycle time of 3 s performed via data-dependent acquisition. The acquired raw mass spectrometry files were analyzed using Proteome Discoverer (v2.5.0) software, and a database search was performed according to the Uniprot Human Proteome Database (June 28, 2023). Other parameters remained at their default values.
[0076] 3.4 Results and Discussion 3.4.1 Effects of different experimental conditions on probe labeling Fluorescent gel results showed that both UV irradiation and lovastatin significantly enhanced probe labeling. Figure 6 a) This is consistent with previous results, and the positions and intensities of the labeled bands in the three biological replicates are similar, indicating that this set of experiments has good reproducibility. The Venn diagram shows that the four sets of experiments collectively identified 3188 proteins ( Figure 6 (b) This includes 71 known isopentenylated proteins and various isopentenyl transferases such as FNTA, as well as proteins related to the isopentenyl pyrophosphate synthesis pathway such as FDPS, indicating that this probe has good application potential in identifying isopentenylated proteins and their interacting proteins.
[0077] 3.4.2 Identification of reported isopentenyl-related proteins under different labeling conditions To further analyze the differences under different labeling conditions, previously reported isopentenylated proteins and proteins that are non-covalently bound to isoprene-like substances were screened from the identified proteins, and their abundance changes under different labeling conditions were compared. The addition of lovastatin significantly enhanced the labeling of several isopentenylated proteins, but had little effect on proteins that are directly non-covalently bound to isoprene-like substances. Figure 7 a), a similar trend was also observed in the experimental group that also received ultraviolet irradiation. Figure 7 (b) This indicates that the addition of lovastatin is important for identifying isopentenylated proteins, and that this probe can effectively analyze isopentenylated proteins. Compared to the experimental group without UV irradiation, the labeling of proteins that directly bind to isoprene-like compounds was significantly improved under UV irradiation. Figure 7 c and d) indicate that the introduction of photoreactive groups can improve the detection of this type of protein, which will help in the discovery of new isoprene-like interacting proteins.
[0078] For identifying isopentenylated proteins, the identification is mainly performed through the cross-linked peptides in sample 2. Currently, suitable mass spectrometry analysis and data processing methods are being developed to further broaden the application scope of this type of probe.
[0079] IV. Geraniol probe labeling and fluorescence imaging analysis of OVCAR-8 cells After photosynthetically labeling cells with geraniol probes, a fluorophore with an azide group can be introduced via a click chemistry reaction, allowing observation of the probe's labeling and distribution within the cells. Adding farnesol as a competitor effectively reduces probe fluorescence labeling, while adding lovastatin or applying UV irradiation enhances it. This method can be used to study the intracellular distribution of isoprene and to verify its interaction with proteins through colocalization experiments.
[0080] 4.1 Experimental Reagents Lovastatin (Maclean), Farnesol (FOH, Bidex Pharmaceuticals), Sodium Chloride (Titan), Chloroform (Titan), 4-Hydroxyethylpiperazine ethanesulfonic acid (HEPES, Genview), Paraformaldehyde (Anaiji). t- Octylphenoxypolyethoxyethanol (Triton X-100, Beyotime), Tris(2-carboxyethyl)phosphine hydrochloride (TCEP, Biotech), 2-(4-((bis(1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic acid (BTTAA, Biotech), Copper sulfate (Bitamin B), 1× phosphate buffer (1×PBS, pH=7.4, Thermo Fisher), DMEM (Thermo Fisher), Fetal bovine serum (FBS, ExCell Bio), Penicillin-streptomycin (PS, Thermo Fisher) Fisher), bovine serum albumin (BSA, Solarbio), Tween-20 (Beyotime), dimethyl sulfoxide (DMSO, Sigma), cell slides (White Shark), DAPI staining solution (BioSharp), anti-fluorescence quenching mounting solution (Beyotime), primary antibody (Proteintech), fluorescent secondary antibody Alexa Fluor 488 (Proteintech).
[0081] 4.2 Experimental Apparatus Pipettes (Thermo Fisher), 365 nm UV lamp (ZF-1), clean bench (Shandong Boke), incubator (Thermo Fisher), pH meter (Sartorius), shaker (Dalong), inverted fluorescence microscope (OLYMPUS, IX73+DP80).
[0082] 4.3 Experimental Procedure OVCAR-8 cells were grown in well plates containing crawler slides. Each well was incubated with medium containing 10 μmol / L lovastatin for 6 hours, followed by incubation with medium containing 10 μmol / L probe and 10 μmol / L lovastatin for 24 hours. The competition group was incubated with 100 μmol / L farnesol and the probe, while the control group was incubated with medium containing the same amount of DMSO. After incubation, the medium was removed, and the cells were washed three times with 1×PBS. The culture dishes were placed on ice and irradiated with a 365 nm UV lamp for 5 minutes. Fixation was performed with 4% paraformaldehyde at room temperature for 15 minutes, followed by washing three times with pre-chilled 1×PBS. HEPES buffer containing 0.1% Triton X-100 was added, and the cells were incubated at room temperature for 20 minutes. TCEP, BTTAA, copper sulfate, and Rhodamine B-PEG3-azide were added to final concentrations of 1 mmol / L, 100 μmol / L, 1 mmol / L, and 10 μmol / L, respectively, and incubated at room temperature for 3 hours. The reaction solution was aspirated, and the slides were washed three times with 1×PBS and stained with DAPI staining solution for 5 minutes. The slides were then removed from the well plate and placed on a glass slide containing anti-fluorescence quenching mounting medium. The edges were sealed with clear nail polish, and the slides were allowed to dry before proceeding with fluorescence detection of probe-labeled cells.
[0083] 4.4 Results and Discussion In cell imaging experiments, the effects of different conditions on photosensitivity geraniol probe labeling were compared. Figure 9 The results showed that UV irradiation significantly enhanced cell fluorescence labeling regardless of the addition of lovastatin; the addition of lovastatin enhanced the probe's fluorescence labeling of cells, while the addition of farnesol significantly reduced the probe's labeling, consistent with the results of fluorescent gel imaging. This experiment further validated the probe's good labeling effect and specificity, demonstrating its potential application value in the study of the isopentenyl pathway and related drug mechanisms of action.
[0084] Example 2 I. Design and Synthesis of Novel Vitamin K2 Photoaffinity Probes This study developed a vitamin K2 photoaffinity probe by introducing photoreactive groups and alkynyl groups into the structure of vitamin K. The probe can covalently label the interacting proteins under ultraviolet irradiation, and then introduce fluorophores or biotin through click chemistry reactions for imaging analysis or protein enrichment, respectively.
[0085] 1.1 Experimental Reagents Geraniol (GOH, Maclean), Pyridine p-toluenesulfonate (PPTS, Xianding), 3,4-Dihydropyran (Dibai), Anhydrous dichloromethane (DCM, Adamas), Methyl tert-butyl ether (MTBE, Sinopharm), Sodium chloride (NaCl, Da Mao), Sodium bicarbonate (NaHCO3, Aladdin), Selenium dioxide (SeO2, Maclean), Salicylic acid (Sinopharm), Tert-butyl hydroperoxide (t-BuOOH, Zesheng), Sodium borohydride (NaBH4, Da Mao), Potassium permanganate (Tieta), N-bromosuccinimide (NBS, Dibai), Dimethyl sulfide (CH3SCH3, Anaiji), Ethyl acetoacetate (EAA, Bide Pharmaceutical), Lithium diisopropylaminodimethyl (LDA, Yanfeng), 3-bromo- 1-(trimethylsilyl)-1-propyne (Dipo), anhydrous tetrahydrofuran (THF, Adamas), sodium hydride (NaH, Anaiji), methanol (Fuyu), potassium hydroxide (KOH, Guoyao), concentrated hydrochloric acid (Tieta), 100-200 mesh silica gel (Aladdin), anhydrous ethanol (Guoyao), anhydrous methanol (Guoyao), ammonia methanol (Anaiji), hydroxylamine-O-sulfonic acid (NH2SO3H, Adamas), anhydrous triethylamine (TEA, Mairuida), iodine (I2, Aladdin), menadione (Dipo), sodium dithionite (Na2S2O4, Titan), boron trifluoride ether (BF3•Et2O, Maclean), ethyl acetate (Titan), 1,4-dioxane (Dioxane, Jizhi).
[0086] 1.2 Experimental Apparatus Pipettes (Thermo Fisher), thermostatic magnetic stirrer (IKA), LTQ Orbitrap Velos Pro high-resolution mass spectrometer (Thermo Fisher), UV spectrophotometer (Shimadzu UV-2600), thermostatic metal bath (Mini H-100), nuclear magnetic resonance spectrometer (Brook), direct-drive rotary vane vacuum pump (Wanpeng Electromechanical), three-in-one UV analyzer (Lichen Technology ZF-1), rotary evaporator (RE-2000 A), low-temperature reaction bath (Zhengzhou Great Wall DHJK-8002), electric heating drying oven (Zhongyi Guoke), thin-layer chromatography silica gel plates (Qingdao Huanghai).
[0087] 1.3 Experimental Procedure 1.3.1 Synthesis and purification of vitamin K2 photoaffinity probe (MK2P) The synthesis route is as follows:
[0088] Compound 1: 9.1 g geraniol (59 mmol, 1.0 equivalence) was dissolved in 15 mL anhydrous dichloromethane. The solution was added to a 100 mL round-bottom flask, and 1.63 g pyridine p-toluenesulfonate (6.49 mmol, 0.11 equivalence) and 21.81 g 3,4-dihydropyran (259.2 mmol, 4.39 equivalence) were added. The mixture was stirred at room temperature for at least 12 hours. The solvent was removed by rotary evaporation. The product was dissolved in methyl tert-butyl ether, washed twice with saturated sodium bicarbonate solution, washed once with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and rotary evaporated to obtain a yellow oily crude product. Purification was achieved by gradient elution using silica gel column chromatography to give a colorless, transparent oily liquid (13.11 g, 93%). Thin-layer chromatography was performed (petroleum ether / ethyl acetate, 9:1, v / v). f = 0.65, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 5.39–5.33 (t, J = 6.0 Hz, 1H), 5.13–5.06 (t, J = 6.0 Hz,1H), 4.65–4.60 (m, 1H), 4.23 (dd, J = 12.0, 6.4 Hz, 1H), 4.03 (dd, J = 11.9, 7.4Hz, 1H), 3.90 (ddd, J = 11.2, 7.7, 3.3 Hz, 4H), 3.53–3.48 (m, 1H), 2.12–2.02(m, 4H), 1.89–1.69 (m, 3H), 1.68 (s, 3H), 1.60 (s, 3H), 1.56–1.50 (m, 3H).
[0089] Compound 2: 12.01 g of compound 1 (50.8 mmol, 1.0 equivalent) was dissolved in 60 mL of anhydrous dichloromethane. The solution was transferred to a 250 mL round-bottom flask and stirred at 0°C. 0.56 g of selenium dioxide (5.05 mmol, 0.1 equivalent) and 0.70 g of salicylic acid (5.07 mmol, 0.1 equivalent) were added, followed by dropwise addition of 27.44 mL of a decane solution of tert-butyl hydroperoxide (5.5 mol / L, 150.92 mmol, 3.0 equivalent). After reacting for 15 minutes, the solution was placed at room temperature (25°C) and stirred for at least 12 hours. The solvent was removed by rotary evaporation. The residue was added to water and extracted three times with an equal volume of methyl tert-butyl ether, washed twice with sodium bicarbonate solution, dried over anhydrous sodium sulfate, filtered, and rotary evaporated to obtain a yellow, oily crude product. The crude product was dissolved in 60 mL of ethanol, and 0.572 g of sodium borohydride (15.1 mmol, 0.3 equivalence) was added at 0 °C. The reaction was allowed to proceed for 1 hour, and the product was observed on a TLC plate until the byproducts visible under UV light completely disappeared. The reaction was quenched with ice water, extracted three times with methyl tert-butyl ether, washed twice with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and then rotary evaporated to obtain a yellow oily crude product. Purification was achieved using silica gel column chromatography with gradient elution to give a colorless, transparent oily liquid (4.896 g, 38%). Thin-layer chromatography (petroleum ether / ethyl acetate, 7:3, v / v) was performed. f = 0.53, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 5.37 (dtd, J = 12.6, 6.6, 1.4 Hz, 2H), 4.65–4.60 (m, 1H), 4.24 (dd, J = 11.7, 6.2 Hz, 1H), 4.02 (dd, J = 11.9, 7.4 Hz, 1H), 3.99 (s, 2H), 3.89 (ddd, J = 11.2, 7.8, 3.3 Hz, 1H), 3.55–3.48 (m, 1H), 2.21–2.05 (m, 4H), 1.87–1.71 (m, 3H), 1.68 (s, 3H), 1.66 (s, 3H), 1.62–1.56 (m,3H).
[0090] Compound 3: In a 100 mL round-bottom flask, 2.40 g of N-bromosuccinimide (13.5 mmol, 1.2 equivalents) was dissolved in 20 mL of anhydrous dichloromethane. The flask was cooled to -35 °C, and 1.21 mL of dimethyl sulfide (16.88 mol, 1.5 equivalents) was added dropwise. The reaction was allowed to proceed for 1 hour, then transferred to an ice bath for 15 minutes. The flask was then cooled back to -35 °C, at which point the reaction solution was opaque and milky yellow. 2.86 g of compound 2 (11.25 mmol, 1.0 equivalents) dissolved in 10 mL of anhydrous dichloromethane was added, and the reaction was allowed to proceed for 10 minutes. The flask was then transferred to room temperature (25 °C) and reacted in the dark for 4 hours, at which point the reaction solution turned transparent yellow. The reaction was quenched with saturated sodium bicarbonate, extracted three times with ethyl acetate, dried over anhydrous sodium sulfate, filtered, and then rotary evaporated to obtain a brownish-red oily crude product. Purification was performed using a short silica gel column, followed by elution with petroleum ether:ethyl acetate = 50:1, yielding a yellow oily liquid (3.05 g, 85%), which was directly used in the synthesis of compound 5. 1 H NMR (400 MHz, CDCl3): δ 5.58 (t, J = 6.7 Hz, 1H), 5.39–5.33 (t, J = 6.7 Hz, 1H),4.65–4.59 (m, 1H), 4.24 (dd, J = 11.9, 6.3 Hz, 1H), 4.02 (dd, J = 12.1, 7.3 Hz,1H), 3.96 (s, 2H), 3.89 (ddd, J = 11.2, 7.5, 3.7 Hz, 1H), 3.51 (dt, J = 11.1, 5.3Hz, 1H), 2.22–2.02 (m, 4H), 1.86–1.77 (m, 3H), 1.75 (s, 3H), 1.67 (s, 3H), 1.63–1.58 (m, 3H).
[0091] Compound 4: A magnetic stir bar was added to a 100 mL round-bottom flask, which was then evacuated and protected with nitrogen. The flask was cooled to -78 °C. 3.01 mL of ethyl acetoacetate (23.8 mmol, 1.0 equivalence) was dissolved in 20 mL of anhydrous tetrahydrofuran and added to the reaction flask. 35.7 mL of a solution of lithium diisopropylaminotetrahydrofuran / hexane (12:25) (2 mol / L, 71.4 mmol, 3.0 equivalence) was slowly added dropwise to the reaction flask. The mixture was reacted at -78 °C for 1 hour, then transferred to an ice bath and reacted for 30 minutes, followed by cooling at -78 °C for 15 minutes. 4.97 g of 3-bromo-1-(trimethylsilyl)-1-propyne (26.0 mmol, 1.1 equivalence) in 20 mL of anhydrous tetrahydrofuran was added, and the mixture was reacted for 1 hour, then transferred to an ice bath and reacted for 30 minutes. The reaction was quenched by adding glacial acetic acid with the mixture under open stirring. Add 50 mL of water and extract the aqueous layer three times with MTBE, wash twice with saturated sodium bicarbonate solution, wash once with saturated sodium chloride solution, dry to anhydrous sodium sulfate, filter, and remove the solvent by rotary evaporation to obtain a dark reddish-brown oily crude product. Purify by gradient elution using silica gel column chromatography to give a yellow oily liquid (4.53 g, 75%). Develop by thin-layer chromatography (petroleum ether / ethyl acetate, 4:1, v / v), R f =0.46, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 4.20 (q, J = 7.2 Hz, 1H), 3.46 (s,1H), 2.81–2.77 (m, 1H), 2.53–2.47 (m, 1H), 1.28 (t, J = 7.2 Hz, 2H), 0.14 (s, 4H).
[0092] Compound 5: A magnetic stir bar was added to a 100 mL double-necked flask. 10 mL of 0.396 g of NaH dissolved in anhydrous tetrahydrofuran (60% purity, 9.9 mmol, 1.1 equivalence) was added with the flask open. The mixture was stirred in an ice bath, and 2.29 g of compound 4 (9.0 mmol, 1.0 equivalence) in 15 mL of anhydrous tetrahydrofuran solution was added dropwise. Gas generation was observed, and the mixture was stirred for 15 minutes. After the gas was completely released, 3.00 g of freshly prepared compound 3 (9.45 mmol, 1.0 equivalence) in 15 mL of anhydrous tetrahydrofuran solution was added. The reaction was allowed to proceed for 15 minutes, then transferred to reflux at 70 °C for at least 16 hours until compound 4 completely disappeared from the thin-layer chromatography. The reaction mixture was cooled to room temperature, and 9 mL of methanol and 18 mL of KOH aqueous solution (3 mol / L) were added. The mixture was then refluxed at 70 °C for approximately 6–16 hours until the intermediate product was observed to have completely disappeared on thin-layer chromatography. The base was neutralized with 54 mL of HCl aqueous solution (1 mol / L), extracted three times with methyl tert-butyl ether, washed twice with saturated sodium bicarbonate solution, washed once with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and the solvent was removed by rotary evaporation to obtain a brownish-red oily crude product. Purification was achieved by gradient elution using silica gel column chromatography to give a yellow oily liquid (1.93 g, 64%). TLC (petroleum ether / ethyl acetate, 8:1, v / v), R f = 0.40, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 5.34 (t, J = 7.0 Hz, 1H), 5.10 (t, J = 7.0 Hz, 1H), 4.61 (t, J = 3.8 Hz, 1H), 4.22 (dd, J = 12.0, 6.4 Hz, 1H), 4.01 (dd, J = 11.9, 7.4Hz, 1H), 3.88 (ddd, J = 11.3, 7.9, 3.0 Hz, 1H), 3.53–3.45 (m, 1H), 2.65 (t, J =7.3 Hz, 2H), 2.50 (t, J = 7.7 Hz, 2H), 2.43 (td, J = 7.4, 2.7 Hz, 2H), 2.25 (t, J =7.8 Hz, 2H), 2.13–1.99 (m, 4H), 1.70 (ddd, J= 12.8, 9.5, 3.6 Hz, 3H), 1.66 (s, 3H), 1.59 (s, 3H), 1.55–1.47 (m, 3H); 13 C NMR (151 MHz, CDCl3): δ 208.25,139.91, 133.88, 124.86, 121.08, 98.01, 83.30, 68.77, 63.81, 62.42, 41.66,41.48, 39.57, 33.57, 30.90, 26.39, 19.79, 16.53, 16.19, 13.10; HRMS, found350.2697 (C 21 H 36 NO3 + [M+NH4] + , requires 350.2690); 355.2267 (C 21 H 32 NaO3 + , [M+Na] + , requires 355.2244); 371.1988 (C 21 H 32 KO3 + [M+K] + (requires 371.1984).
[0093] Compound 6: 0.86 g of compound 5 (2.6 mmol, 1.0 equivalent) was dissolved in 20 mL of anhydrous ethanol. The solution was added to a 50 mL round-bottom flask, and 65.30 mg of pyridine p-toluenesulfonate (0.26 mmol, 0.1 equivalent) was added. The mixture was stirred at 60 °C for 4 hours, and the solvent was removed by rotary evaporation to obtain a yellow, oily crude product. Purification was achieved by gradient elution using silica gel column chromatography to give a pale yellow, oily liquid (0.359 g, 56%). Thin-layer chromatography (petroleum ether / ethyl acetate, 4:1, v / v) was performed. f = 0.30, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 5.42–5.36 (m, 1H), 5.13–5.07 (m, 1H), 4.15 (d, J = 6.9 Hz, 2H), 2.66 (dd, J = 8.1, 6.5 Hz, 2H), 2.52 (t, J= 7.6 Hz, 2H), 2.44(td, J = 7.4, 2.7 Hz, 2H), 2.30–2.24 (m, 2H), 2.14–2.00 (m, 4H), 1.95 (t, J = 2.7Hz, 1H), 1.67 (s, 3H), 1.60 (s, 3H); 13 C NMR (151 MHz, CDCl3) : δ 208.42, 139.27,133.87, 124.73, 123.89, 83.28, 68.79, 59.47, 41.54, 41.41, 39.42, 33.52,26.24, 16.31, 16.18, 13.09; HRMS, found 249.1852 (C 16 H 25 O2 + , [M+H] + , requires249.1850); 266.2115 (C 16 H 28 NO2 + , [M+NH4] + , requires 266.2115); 271.1667(C 16 H 24 NaO2 + , [M+Na] + , requires 271.1669); 287.1415 (C 16 H 24 KO2 + , [M+K] + , requires287.1408).
[0094] Compound 7: A magnetic stir bar was added to a 50 mL round-bottom flask, which was then evacuated and protected with nitrogen, and cooled to -78 °C. 0.245 g of compound 6 (1 mmol, 1.0 equivalent) was dissolved in a small amount of anhydrous methanol and added to the reaction flask. Then, 5.14 mL of ammonia-methanol solution (7 mol / L, 36 mmol, 36.0 equivalent) was slowly added dropwise. After stirring for 10 minutes, the mixture was placed at 37 °C and stirred in the dark for at least 5 hours. It was then cooled again to -78 °C. 0.8 mL of anhydrous methanol solution containing 0.13 g of hydroxylamine-O-sulfonic acid (1.15 mmol, 1.15 equivalent) was added, and the mixture was kept at -78 °C for 0.5 hours. Then, it was stirred at 37 °C for at least 1 hour, followed by stirring overnight at room temperature (25 °C). A white precipitate formed. The precipitate was filtered, the residue was washed with methanol, and the filtrate was concentrated under reduced pressure and dissolved in 1 mL of anhydrous dichloromethane. Add 0.1733 mL of anhydrous TEA (1.25 mmol, 1.25 equivalents) at 0 °C, then add 10 mL of a saturated dichloromethane solution of I₂ and stir until a persistent orange-brown color (which does not fade) appears. After maintaining this state for 1 hour, evaporate the dichloromethane to obtain the crude product, which is stored at 4 °C protected from light. Purify by gradient elution using silica gel column chromatography to give a pale yellow oily liquid (63.1 mg, 24%). Develop by thin-layer chromatography (petroleum ether / ethyl acetate, 2:1, v / v), R f = 0.62, potassium permanganate color development. 1 HNMR (600 MHz, CDCl3): δ 5.41 (t, J = 6.9 Hz, 1H), 5.12 (t, J = 6.8 Hz, 1H), 4.15(d, J = 7.0 Hz, 2H), 2.15–2.02 (m, 4H), 2.02–1.95 (m, 2H), 1.79 (dd, J = 9.7, 6.5Hz, 2H), 1.68 (s, 3H), 1.62 (t, J = 7.4 Hz, 2H), 1.55 (s, 3H), 1.54–1.46 (m,2H); 13 C NMR (151 MHz, CDCl3): δ 139.67, 133.82, 124.96, 123.70, 83.03, 69.17,59.56, 39.46, 33.60, 32.50, 31.57, 28.33, 26.37, 16.41, 16.07, 13.47; HRMS, found 278.2330 (C 16 H 28N3O + [M+NH4] + , requires 278.2227); 299.1523 (C 16 H 24 KN2O + [M+K] + (requires 299.1521).
[0095] Vitamin K2 photoaffinity probe (compound 8, MK2P): 51.6 mg of menadione (0.3 mmol, 1.5 equivalent) and 105 mg of sodium dithionite (0.3 mmol, 3.0 equivalent) were placed in a 10 mL round-bottom flask, evacuated under nitrogen protection, and 1 mL each of water and methyl tert-butyl ether were added using a syringe. The mixture was stirred vigorously for 30 minutes in the dark until the organic phase changed from dark brown to pale yellow. After separating the organic phase, the mixture was dried over anhydrous sodium sulfate and rapidly rotary evaporated to obtain a white solid. The solid was then dissolved under nitrogen protection by adding 1 mL of 1,4-dioxane. 52.4 mg of compound 7 (0.2 mmol, 1.0 equivalent) in 0.75 mL of ethyl acetate and 21 μL of boron trifluoride diethyl ether were added, and the mixture was stirred at 70 °C for at least 3 hours. The mixture was purified by gradient elution using silica gel column chromatography to obtain a pale yellow oily liquid (4.7 mg, 10%). Thin-layer chromatography development (petroleum ether / dichloromethane / ethyl acetate, 2:1:0.05, v / v / v), R f = 0.43, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 8.12–8.06 (m, 1H), 7.72–7.66 (m, 1H), 5.08–4.99 (m,2H), 3.37 (d, J = 7.0 Hz, 2H), 2.19 (s, 3H), 2.09–1.93 (m, 7H), 1.79 (s, 3H), 1.76–1.71 (m, 2H), 1.61–1.56 (m, 2H), 1.51 (s, 3H), 1.48–1.43 (m, 2H); 13 C NMR (151 MHz, CDCl3): δ185.59, 184.66, 146.33, 143.53, 137.47, 133.67, 133.50,133.45, 132.43, 132.40, 126.48, 126.40, 125.08, 119.51, 83.04, 69.14, 39.64,33.58, 32.51, 31.63, 29.85, 26.61, 26.20, 16.56, 16.06, 13.46, 12.81; HRMS, found 415.2379 (C 27 H 31 N2O2 + [M+H] + , requires 415.2381); 432.2644 (C 27 H 34 N3O2 + [M+NH4] + , requires 432.2646); 437.2195 (C 27 H 30 N2NaO2 + , [M+Na] + , requires 437.2200.
[0096] 1.3.2 Synthesis and purification of vitamin K2 control probe (MK2CP) The synthesis route is as follows:
[0097] Compound 9: 0.2544 g of compound 3 (1.0 mmol, 1.0 equivalence) was dissolved in 3 mL of anhydrous tetrahydrofuran and added to a sealed tube. 0.120 g of NaH (60%, 3.0 mmol, 3.0 equivalence) in 3 mL of anhydrous tetrahydrofuran was added under ice bath conditions. After stirring for 90 min, 0.4758 g of 3-bromopropyne (4.0 mmol, 4.0 equivalence) was dissolved in 4 mL of anhydrous tetrahydrofuran and pre-cooled at 0 °C. This solution was added to the sealed tube within 1 minute, and the cap was tightened until it was just about to stop. The reaction was carried out at 70 °C for at least 12 h. The reaction was quenched with water, extracted three times with MTBE, washed twice with saturated sodium bicarbonate solution, washed once with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and the solvent was removed by rotary evaporation to obtain a brownish-yellow oily crude product. Purification was achieved by gradient elution using silica gel column chromatography to obtain a yellow oily liquid (243.7 mg, 83%). Thin-layer chromatography development (petroleum ether / ethyl acetate, 4:1, v / v), R f = 0.65, potassium permanganate color development.1 H NMR (600 MHz, CDCl3): δ 5.43 (t, J = 6.4 Hz, 1H), 5.37 (t, J = 6.2 Hz, 1H), 4.62 (dd, J = 4.5, 3.0 Hz, 1H), 4.24 (dd, J = 12.2, 6.7Hz, 1H), 4.07 (d, J = 2.4 Hz, 2H), 4.02 (dd, J = 12.0, 7.3 Hz, 1H), 3.93 (s, 2H), 3.89 (ddd, J = 11.2, 7.7, 3.4 Hz, 1H), 3.54–3.48 (m, 1H), 2.40 (t, J = 2.4 Hz, 1H), 2.18 (q, J = 7.6 Hz, 2H), 2.08 (dd, J = 9.0, 6.3 Hz, 2H), 1.88–1.69 (m, 3H), 1.68 (s, 3H), 1.65 (s, 3H), 1.61–1.57 (m, 3H).
[0098] Compound 10: A 10 mL anhydrous ethanol solution of 0.2437 g of compound 9 (0.834 mmol, 1.0 equivalent) was added to a 50 mL round-bottom flask, along with 21.0 mg of pyridine p-toluenesulfonate (0.084 mmol, 0.1 equivalent). The mixture was stirred at 60 °C for 4 hours, and the solvent was removed by rotary evaporation to obtain a yellow, oily crude product. Purification was achieved by gradient elution using silica gel column chromatography to give a pale yellow, oily liquid (137.5 mg, 79%). Thin-layer chromatography was performed (petroleum ether / ethyl acetate, 4:1, v / v). f = 0.28, potassium permanganate color development. 1 H NMR (600 MHz, CDCl3): δ 5.42 (dd, J = 7.0, 1.4 Hz, 2H), 4.15 (d, J =6.9 Hz, 2H), 4.08 (d, J = 2.4 Hz, 2 H), 3.93 (s, 2H), 2.41 (t, J= 2.4 Hz, 1H), 2.18 (q, J = 7.4 Hz, 2H), 2.08 (t, J = 7.7 Hz, 2H), 1.68 (s, 3H), 1.65 (s, 3H); 13 CNMR (151 MHz, CDCl3): δ 139.25, 131.83, 128.92, 124.00, 80.16, 75.91, 74.24,59.51, 56.58, 39.15, 26.10, 16.33, 14.09; HRMS, found 231.1346 (C 13 H 20 NaO2 + , [M+Na] + , requires 231.1356); 247.1086 (C 13 H 20 KO2 + [M+K] + (requires 247.1095).
[0099] Vitamin K2 control probe (compound 11, MK2CP): 51.6 mg of menadione (0.3 mmol, 1.5 equivalent) and 105 mg of sodium dithionite (0.3 mmol, 3.0 equivalent) were placed in a 10 mL round-bottom flask under vacuum and nitrogen protection. 1 mL each of water and MTBE were added using a syringe, and the mixture was stirred vigorously for 30 minutes in the dark, protected from light, until the organic phase changed from dark brown to pale yellow. The organic phase was separated, dried over anhydrous sodium sulfate, and rapidly rotary evaporated to obtain a white solid. The solid was dissolved under vacuum and nitrogen protection by adding 1 mL of 1,4-dioxane. 41.6 mg of compound 10 (0.2 mmol, 1.0 equivalent) in 0.75 mL of ethyl acetate and 21 μL of boron trifluoride diethyl ether were added, and the mixture was stirred at 70 °C for at least 3 hours. Purification was achieved by gradient elution using silica gel column chromatography to obtain a pale yellow oily liquid (18 mg, 25%). Thin-layer chromatography was performed (petroleum ether / dichloromethane / ethyl acetate, 2:1:0.05, v / v / v). f = 0.23, potassium permanganate color development. 1 H NMR (600MHz, CDCl3): δ 8.11–8.05 (m, 1H), 7.73–7.65 (m, 1H), 5.37 (t, J= 7.2 Hz, 1H),5.05–5.00 (m, 1H), 4.03 (s, 2H), 3.87 (s, 2H), 3.37 (d, J = 7.0 Hz, 2H), 2.37(t, J = 2.2 Hz, 1H), 2.19 (s, 3H), 2.13 (q, J = 7.5 Hz, 2H), 2.07–2.01 (m, 2H), 1.79 (s, 3H), 1.62 (s, 3H); 13 C NMR (151 MHz, CDCl3): δ 185.59, 184.66, 146.22,143.57, 137.24, 133.50, 133.45, 132.38, 132.35, 131.64, 128.96, 126.47,126.37, 119.67, 80.16, 75.87, 74.18, 56.50, 39.35, 26.31, 26.18, 16.49,14.06, 12.83; HRMS, found 385.1761 (C 24 H 26 NaO3 + , [M+Na] + (requires 385.1775).
[0100] 1.3.3 Synthesis and Purification of Vitamin K Derivatives (MK2) The synthesis route is as follows:
[0101] Compound 12 (MK2): A 15 mL solution of 2.00 g menadione (11.6 mmol, 1.0 equivalence) in ethyl acetate and a 15 mL solution of 4.55 g sodium dithionite (23.2 mmol, 2.0 equivalence) in aqueous solution were mixed in a separatory funnel. The organic phase was initially blue-purple upon contact, then turned reddish-black. The mixture was shaken vigorously for 15-20 minutes until the organic phase decolorized. The organic phase was dried over anhydrous sodium sulfate and filtered. Rotary evaporation yielded a white naphthyldiol intermediate. The mixture was immediately evacuated and protected with nitrogen. 15 mL of ethyl acetate and 15 mL of 1,4-dioxane were added to dissolve the solid. 1.79 g geraniol (11.6 mmol, 1.0 equivalence) was added with stirring, followed by the slow addition of 0.812 mL of boron trifluoride diethyl ether. The mixture was stirred at 70 °C for 3 hours. The reaction was quenched with water, extracted three times with ethyl acetate, washed twice with saturated sodium bicarbonate solution, washed once with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and the solvent was removed by rotary evaporation to obtain a dark brown paste-like crude product. Purification was performed using silica gel column chromatography with gradient elution to give a deep yellow oily liquid (608 mg, 17%). Thin-layer chromatography (petroleum ether / ethyl acetate, 20:1, v / v) was performed. f = 0.57, potassium permanganate color development. 1 H NMR (400 MHz, CDCl3): δ 8.12–8.00 (m, 2H), 7.73–7.64 (m, 2H), 5.07–4.96 (m, 2H), 3.37 (d, J =7.0 Hz, 2H), 2.18 (s, 3H), 2.10–1.94 (m, 4H), 1.78 (s, 3H), 1.62 (s, 3H), 1.56 (s, 3H).
[0102] 1.3.3 Probe Concentration Determination Prepare a 100 mmol / L DMSO solution with MK2, and then dilute it to 10 mmol / L and 1 mmol / L DMSO solutions. Prepare standard solutions (containing 0.5% DMSO) with anhydrous ethanol at concentrations of 2 μmol / L, 5 μmol / L, 10 μmol / L, 20 μmol / L, and 50 μmol / L. Weigh MK2P, MK2CP, and MK4 separately, dissolve them in DMSO to prepare a 20 mmol / L stock solution, and then dilute it with anhydrous ethanol to a theoretical concentration of 20 μmol / L. Measure the absorbance of the MK2 standard solution and the test solutions MK2P, MK2CP, and MK4 in the 235-400 nm range. Plot a standard curve based on the absorbance at the maximum absorption wavelength of 262 nm, and calculate the actual concentrations of the test solutions and the stock solution.
[0103] 1.4 Results and Discussion Since the naphthoquinone ring of vitamin K is its main redox active site, modification was chosen on the isopentenyl side chain. By introducing smaller photoreactive groups and bioorthogonal alkynyl groups onto the isopentenyl side chain of MK2, the impact of modification on its function was reduced, better mimicking the interaction between vitamin K and its binding proteins. The side chain of vitamin K2 (MK4) contains four isopentenyl units (…). Figure 10 a) In the design, the side chain length of the vitamin K2 photoaffinity probe MK2P was considered to be close to that of MK4. At the same time, a vitamin K2 control probe MK2CP without photoreactive groups was synthesized as a comparison. Figure 10 b). Since the probe contains only two isopentenyl units, we also synthesized the vitamin K2 derivative MK2.
[0104] MK2P covalently modifies proteins using the photoreactive group bisacrylidine. After the probe enters the cell, it binds to the target protein, and the photoreactive group can covalently link the probe to the bound protein under 365nm ultraviolet light. Figure 11 The alkyne group carried by the probe can undergo a click chemical reaction with rhodamine containing an azide group, thereby enabling fluorescent gel imaging or cell imaging analysis of the labeled protein; the alkyne group can also react with biotin azide, enriching the labeled protein with streptavidin agar beads, followed by mass spectrometry detection, thereby enabling high-throughput screening and identification of target proteins.
[0105] Due to the limited amount of probe used, the UV absorption spectra of MK2P and MK2CP were characterized and their concentrations determined to ensure accuracy. First, MK2 was synthesized as a standard, and standard solutions with varying concentrations were prepared. The UV absorption spectra of the standard solutions and probes in the 235-400 nm range were measured. The maximum absorption wavelengths of the probes were 262 nm, 269 nm, and 328 nm, the same as those of MK2 and MK4. Figure 12 a) indicates that the modifying groups have little effect on its UV absorption. A standard curve for MK2 solution was plotted using the absorbance at 262 nm. Figure 12 b), and the actual concentrations of MK2P, MK2CP and MK4 solutions were corrected according to the standard curve. The results showed that the theoretical concentration was not much different from the actual concentration, which ensured the accuracy of the probe and vitamin K concentration used in subsequent experiments (Table 1).
[0106] Table 1 Concentration Correction for MK2P, MK2CP, and MK4
[0107] II. Vitamin K2 probe labeling of HEK 293T cells and protein fluorescence gel imaging analysis First, the labeling of proteins in live cells by vitamin K2 photoaffinity probes and control probes was analyzed using fluorescent gel electrophoresis. The probes were dissolved in culture medium and incubated with cells for a certain period. Then, the cells were irradiated with 365 nm ultraviolet light to covalently link the probes to the proteins they bound. The proteins were extracted, linked to fluorophores, and then separated using SDS-PAGE. Fluorescence imaging analysis was performed on the gels. Based on the fluorescence intensity of the protein bands under different conditions, appropriate probe concentrations, incubation times, and ultraviolet irradiation times were selected to ensure good labeling effects.
[0108] 2.1 Experimental Reagents Methanol (Fuyu), glacial acetic acid (Fuyu), vitamin K2 (Maclean), sodium chloride (Titan), chloroform (Titan), 4-hydroxyethylpiperazine ethanesulfonic acid (HEPES, Genview) t - Octylphenoxypolyethoxyethanol (Triton X-100, Beyotime), Tris(2-carboxyethyl)phosphonic acid hydrochloride (TCEP, Biotech), 2-(4-((bis(1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic acid (BTTAA, Biotech), Copper sulfate (Biotech), Dodecyl sulfate (SDS, Genview), 30% Acrylamide (Dingguo), Bromophenol blue (Biotech), Coomassie Brilliant Blue R-250 (Soluble), Protein Marker (Thermo Fisher), β-mercaptoethanol (Biotech), Tris(hydroxymethyl)aminomethane hydrochloride (Tris•HCl, Soluble), Protease inhibitor (Aimer), BCA kit (Beyotime), DMEM medium (Thermo Fisher), Fetal bovine serum (FBS, ExCell Bio), Penicillin-streptomycin (PS, Thermo Fisher) Fisher), 1× phosphate buffer (1×PBS, pH = 7.4, Thermo Fisher), dimethyl sulfoxide (DMSO, Sigma), RIPA lysis buffer (Beyotime), HEPES buffer (50 mmol / L HEPES, 150 mmol / L sodium chloride, pH = 7.4).
[0109] 2.2 Experimental Apparatus Pipettes (Thermo Fisher), centrifuges (Eppendorf), thermostatic metal bath (Mini H-100), microplate reader (Bio-Rad), electrophoresis apparatus (Bio-Rad), 365 nm UV lamp (ZF-1), vortex apparatus (IKA), Amersham Typhoon 5 multispectral laser imager (Cytiva), clean bench (Shandong Boke), incubator (Thermo Fisher).
[0110] 2.3 Experimental Procedure Fluorescent gel imaging of HEK 293T cells labeled with vitamin K2 probe. HEK293T cells were cultured in DMEM medium at 37°C and 5% CO2 until the cell density reached 90% before administration of the drug. Each well was incubated with DMEM medium containing 10 μmol / L MK2P or MK2CP for 4 hours. For competition experiments, each well was incubated with medium containing 100 μmol / L MK2 or MK4 for 2 hours, followed by incubation with medium containing 10 μmol / L probe and 100 μmol / L competitor for 4 hours. The control group was treated with medium containing the same DMSO concentration. After incubation, the medium was removed, and the cells were washed three times with 1×PBS. The culture dishes were placed on ice and irradiated with a 365 nm UV lamp for 5 minutes. After removing the cells from the culture dishes, they were collected by centrifugation. RIPA lysis buffer (containing 1% protease inhibitor) was added, and the cells were lysed on ice for 30 minutes, followed by centrifugation at 10,000 rpm for 30 minutes at 4°C. The protein concentration in the supernatant was determined using a BCA kit. 100 μg of protein was taken, and HEPES buffer containing 0.1% Triton X-100 was added to bring the final protein concentration to 1 mg / mL. Then, TCEP, BTTAA, copper sulfate, and Rhodamine B-PEG3-azide (RB-N3) were added to bring the final concentrations to 1 mmol / L, 100 μmol / L, 1 mmol / L, and 100 μmol / L, respectively. The mixture was vortexed at room temperature for 3 hours. Ten volumes of methanol were added, and the mixture was incubated overnight at -20°C. The precipitate was centrifuged at 10,000 rpm, and the protein precipitate was retained. The precipitate was dissolved in buffer containing 4% SDS before measuring the protein concentration. The protein solution was then added to 4× loading buffer, heated at 95°C for 5 minutes, and subjected to polyacrylamide gel electrophoresis. Fluorescence gel imaging analysis was performed on an Amersham Typhoon 5 multispectral laser imager.
[0111] 2.4 Results and Discussion 2.4.1 Optimization of Vitamin K2 Photoaffinity Probe Labeling Conditions To find suitable probe labeling conditions, the effects of probe concentration, incubation time, and UV irradiation time on probe-labeled proteins were first analyzed using fluorescence gel imaging experiments.
[0112] Fluorescent gel imaging results showed that the intensity of the labeled protein bands increased with increasing probe concentration, indicating a concentration-dependent labeling effect. Figure 14 a) The probe showed significant labeling even at a low concentration of 2 μmol / L, indicating good labeling efficiency. Although increasing the probe concentration could significantly enhance the labeling effect, considering that high-concentration probes might increase non-specific labeling and that vitamin K has poor solubility in aqueous solution, a probe concentration of 10 μmol / L was ultimately chosen for labeling.
[0113] Fluorescent gel imaging showed that probe labeling increased with increasing probe incubation time, but the change was not significant after 4 hours. Therefore, 4 hours was chosen as the probe incubation time in subsequent experiments. Figure 14 b). As UV irradiation time increased, protein band labeling intensified. Noticeable labeling was observed after 2 minutes of UV irradiation, and although labeling slightly increased after 5 minutes, the difference was not significant. Figure 14 c). Since the cells remain viable during UV irradiation, prolonged UV irradiation may alter the cell state and affect the analysis results. Therefore, 5 minutes was chosen as the UV irradiation time for photoaffinity probe labeling.
[0114] In summary, a probe concentration of 10 μmol / L, an incubation time of 4 hours, and an ultraviolet irradiation time of 5 minutes were selected as the conditions for photoaffinity probe labeling of HEK 293T live cells.
[0115] 2.4.2 Competitive effect of vitamin K on probe labeling After determining the probe labeling conditions, a competition experiment was conducted using MK4 and MK2 to label the probes. Since MK4 or MK2 competes with the probe for the same binding pocket after entering the cell, it reduces the labeling of vitamin K-binding proteins. Fluorescent gel electrophoresis results showed that the labeling intensity of the probe decreased with increasing competitor concentration, indicating that the probe labeling has a certain degree of specificity. MK2 could compete for most of the labeled bands at a concentration 5 times that of the probe, while MK4's competitive effect on probe labeling was weaker than MK2. This difference may be due to different solubilities; MK2 is more water-soluble than MK4, and at higher concentrations, a small amount of MK4 may be observed to precipitate, potentially leading to a lower actual concentration of MK4 than MK2, thus weakening its competitive effect.
[0116] 2.4.3 Vitamin K2 control probe for cell labeling In the absence of photoreactive groups, the control probe molecule itself cannot form a covalent bond with the protein. However, the fluorescent gel results showed that MK2CP also labeled HEK293T cells, but the labeling intensity was weaker than that of MK2P, and the labeling bands of the two also differed. Figure 16a). In MK2CP labeling, the labeling intensity increases with increasing probe concentration and incubation time, and excessive MK4 also reduces MK2CP labeling ( Figure 16 (bd). The above results indicate that although there are no photoreactive groups, MK2CP can still covalently label proteins, and the labeling has a certain degree of specificity. The reasons for this labeling need further investigation.
[0117] III. Labeling and Proteomic Analysis of HEK293T Cells Using Vitamin K2 Probes After determining the optimal labeling conditions for MK2P using fluorescent gel imaging experiments, the proteins labeled by the vitamin K2 photoaffinity probe were further analyzed using probe-labeled and label-free quantitative proteomics methods. After incubating the probe in live cells for 4 hours, it formed a covalent link with its binding protein under UV irradiation. Biotin was then introduced via a click chemistry reaction, and the labeled proteins were enriched for mass spectrometry analysis. Adding excess VK2 as a competitor during probe incubation significantly reduced the labeling of VK2-binding proteins. Based on the difference in mass spectrometric signal abundance between the probe group and the competition group, proteins with significantly reduced signals in the competition group were screened as potential vitamin K interacting proteins.
[0118] 3.1 Experimental Reagents Formic acid (FA, Thermo Fisher), acetonitrile (ACN, Thermo Fisher), glacial acetic acid (Fuyu), ammonium bicarbonate (Bide Pharmaceuticals), 2-iodoacetamide (IAA, Bide Pharmaceuticals), urea (Genview), biotin-DADPS-azide (Leyan), methanol (Fuyu), protein marker (Thermo Fisher), sodium chloride (Titan), chloroform (Tieta), 4-hydroxyethylpiperazine ethanesulfonic acid (HEPES, Genview) t- Octylphenoxypolyethoxyethanol (Triton X-100, Beyotime), Tris(2-carboxyethyl)phosphonic acid hydrochloride (TCEP, Biotech), 2-(4-((bis(1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic acid (BTTAA, Biotech), Copper sulfate (Bitatech), Sodium dodecyl sulfate (SDS, Genview), 30% acrylamide (Dingguo), Bromophenol blue (Bitatech), Coomassie Brilliant Blue R-250 (Solepro), β-mercaptoethanol (Bitatech), Tris(hydroxymethyl)aminomethane hydrochloride (Tris•HCl, Solepro), Protease inhibitor (Aimer), BCA kit (Beyotime), DMEM medium (Thermo Fisher), Fetal bovine serum (FBS, ExCell Bio), Penicillin-streptomycin (PS, Thermo Fisher) Fisher), 1× phosphate buffer (1×PBS, pH=7.4, Thermo Fisher), dimethyl sulfoxide (DMSO, Sigma), RIPA lysis buffer (Beyotime), sodium hydroxide (Sinopharm), streptavidin microbeads (Thermo Fisher), and mass spectrometry grade trypsin (Thermo Fisher).
[0119] 3.2 Experimental Apparatus Centrifuge (Eppendorf), 365 nm UV lamp (ZF-1), 0.22 μm filter membrane (Agela), constant temperature metal bath (Mini H-100), ultrasonic cleaner (Shandong Boke), C18 Tip (Thermo Fisher), high resolution mass spectrometer (Orbitrap Exploris 480), ultra-high performance liquid chromatography system (Vanquish Neo UHPLC), centrifuge (Eppendorf), microplate reader (Bio-Rad), vortex apparatus (IKA), horizontal shaker (Dalong), electrophoresis apparatus (Bio-Rad), pH meter (Sartorius), rotary shaker (Thermo Fisher).
[0120] 3.3 Experimental Procedure 3.3.1 Preparation of probe-labeled mass spectrometry samples of HEK293T cells by on-Beads enzymatic digestion method HEK293T cells were cultured in DMEM medium at 37°C and 5% CO2 until the cell density reached 90% before administration of the drug. Each well was incubated with DMEM medium containing 10 μmol / L MK2P or MK2CP for 4 hours. For competition experiments, each well was incubated with medium containing 100 μmol / L MK2 or MK4 for 2 hours, followed by incubation with medium containing 10 μmol / L probe and 100 μmol / L competitor for 4 hours. The control group was treated with medium containing the same DMSO concentration. After incubation, the medium was removed, and the cells were washed three times with 1×PBS. The culture dishes were placed on ice and irradiated with a 365 nm UV lamp for 5 minutes. After removing the cells from the culture dishes, they were collected by centrifugation. RIPA lysis buffer (containing 1% protease inhibitor) was added, and the cells were lysed on ice for 30 minutes, followed by centrifugation at 10,000 rpm for 30 minutes at 4°C. The protein concentration in the supernatant was determined using a BCA kit. 1 mg of protein was taken, and HEPES buffer containing 0.1% Triton X-100 was added to bring the final protein concentration to 1 mg / mL. Then, TCEP, BTTAA, copper sulfate, and biotin-DADPS-azide were added to bring the final concentrations to 1 mmol / L, 100 μmol / L, 1 mmol / L, and 100 μmol / L, respectively. The mixture was vortexed at room temperature for 3 hours. Ten volumes of methanol were added, and the mixture was incubated overnight at -20°C. The precipitate was centrifuged at 10,000 rpm, and the protein precipitate was retained. The precipitate was dissolved in buffer containing 4% SDS, and HEPES buffer was added to bring the final volume to 1 mL. Streptavidin beads were washed with HEPES buffer and added to the sample. The mixture was incubated on a rotary shaker at room temperature for 3 hours. The sample was transferred to a centrifuge filter column and washed with 1×PBS, 1×PBS, 10×PBS, 1×PBS, and 25 mmol / L ammonium bicarbonate solution containing 1% SDS, respectively. The microbeads were then transferred to centrifuge tubes using a 50 mmol / L ammonium bicarbonate solution containing 8 mol / L urea, and the solution was added to a total volume of 1 mL. TCEP solution was added to a final concentration of 20 mmol / L, and the reaction was carried out at 37°C for 1 hour. IAA was then added to a final concentration of 50 mmol / L, and the reaction was carried out at room temperature (25°C) in the dark for 30 minutes. The supernatant was removed by centrifugation, and the mixture was washed three times with 25 mmol / L ammonium bicarbonate solution. 100 μL of a 25 mmol / L ammonium bicarbonate solution containing 1 μg / μL mass spectrometry-grade trypsin was added, and the mixture was incubated at 37°C for 16 hours. After enzymatic digestion, the supernatant was transferred to a new centrifuge tube, washed three times with 25 mmol / L ammonium bicarbonate solution, and the supernatants were combined and concentrated by centrifugation to obtain the sample. The sample was desalted using a C18 Tip solution, and after centrifugation and concentration, the desalted sample was dissolved in 10 μL of water (HPLC grade), with an injection volume of 6 μL.
[0121] 3.3.2 LC-MS / MS Detection and Analysis Methods Detection was performed using a Vanquish Neo liquid chromatography-tandem Orbitrap Exploris 480 mass spectrometer. A self-prepared nano-liquid C18 capillary column was used, with a column packing particle size of 3 μm, an inner diameter of 75 μm, and a length of 18 cm. Mobile phase A was water containing 0.1% FA, and mobile phase B was acetonitrile containing 0.1% FA. The flow rate was 300 nL / min, and gradient elution was used to separate peptides. The Orbitrap Exploris 480 was used in positive ion detection mode, with a primary full scan and a secondary scan with a cycle time of 3 s performed via data-dependent acquisition. The acquired raw mass spectrometry files were analyzed using Proteome Discoverer (v2.5.0) software, and a database search was performed according to the Uniprot Human Proteome Database (June 28, 2023). Other parameters remained at their default values.
[0122] 3.4 Results and Discussion 3.4.1 Analysis of the effect of MK4 competition on probe labeling using label-free quantitative proteomics methods Previous fluorescent gel results showed that both MK2 and MK4 competed for MK2P labeling, but MK4 was less competitive than MK2. Figure 18 Since MK4 is a naturally occurring vitamin K2, the competition results of MK4 were analyzed first. HEK293T live cells were labeled with 10 μmol / L MK2P as the probe group, and MK4 at 100 μmol / L was incubated for 2 hours before being co-incubated with the 10 μmol / L probe as the competition group. Peptide samples were prepared using the on-Beads enzymatic digestion method and analyzed by LC-MS / MS. The obtained mass spectrometry data were analyzed using Proteome Discoverer 2.5 software for peptide assignment and quantification.
[0123] To ensure data reliability, five biological replicates were performed. Venn diagrams showed that in each of the five MK4 competition experiments, more than 4300 proteins were identified, with 3841 proteins being repeatedly identified, indicating good reproducibility. Quantitative analysis was performed on the proteins identified in all five experiments. The ratio of protein abundance detected by the probe group to the competition group in each group was averaged; the p-value was obtained through a t-test, and the p-value was plotted with log2ratio(MK2P / MK4) on the x-axis. 10Using p-value as the ordinate, a volcano plot was obtained to reflect the results of protein quantification analysis in the MK4 competition experiment. Within the range of ratio > 1.5 and p-value < 0.05, a total of 828 proteins were identified, including four known vitamin K-binding proteins: VKORC1L1, NPC1L1, GGCX, and UBIAD1, demonstrating the reliability of the mass spectrometry data and screening method.
[0124] Gene Ontology (GO) analysis was performed on the 828 selected proteins, classifying them according to their biological processes, cellular components, molecular functions, and involved pathways. The results showed that proteins screened by the MK4 competition assay were significantly enriched in various organelle membranes such as the endoplasmic reticulum, Golgi apparatus, and mitochondria, consistent with the lipid-soluble nature of vitamin K. In molecular function and biological process analysis, proteins related to cellular response to oxidative stress and protein disulfide reductases were significantly enriched, consistent with previously reported functions of VK, such as inhibiting ferroptosis and being reduced by protein disulfide isomerases like TMX1. KEGG enrichment analysis revealed that several proteins are associated with diseases caused by vitamin K abnormalities, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and various neurodegenerative diseases, suggesting that these probe-enriched proteins may mediate the important role of vitamin K in these diseases. In addition, several proteins related to protein processing on the endoplasmic reticulum were enriched, and the interaction between vitamin K and these proteins has not yet been reported, warranting further investigation.
[0125] 3.4.2 Analysis of the effect of MK2 competition on probe labeling using label-free quantitative proteomics methods Based on previous results of fluorescent gel competition experiments, MK2 exhibits stronger competitive performance against MK2P probe labeling than MK4. Figure 19 To compare the differences in proteins screened by the two competing agents, the quantitative results of MK2 competition were analyzed using the same method.
[0126] As shown in the Venn diagram, in each of the five MK2 competition experiments, more than 4200 proteins were identified, of which 3866 proteins were repeatedly identified, indicating good data reproducibility. Figure 19 a). Five experiments screened out 864 possible vitamin K binding proteins, including known binding proteins such as UBIAD1, VKORC1L1, and NPC1L1. GGCX was also identified simultaneously by all five datasets, with an average ratio greater than 2, although the p-value was slightly lower, possibly due to poor reproducibility of the data collection method. Figure 19(b) Comparing the mass spectrometry results of the two competing agents, it can be seen that the overall ratio of histone competition by MK4 is lower. This is actually due to the fact that the competitive effect of MK4 is not as good as that of MK2, which is consistent with the results of fluorescent gel chromatography. Both methods can effectively identify known VK-binding proteins, indicating that the method and the quantitative mass spectrometry data have good reliability.
[0127] The 864 selected proteins were also analyzed using GO and KEGG methods. Similar to the results of the MK4 competition experiment, proteins located on organelle membranes and nuclear membranes were significantly enriched. These proteins are involved in processes such as inter-organelle transport and oxidative phosphorylation, and are involved in functions such as transport, redox reactions, and protein folding. These functions are also closely related to the transport and physiological effects of vitamin K in vivo.
[0128] IV. Cell imaging analysis of vitamin K2 photoaffinity probes labeled HT1080 and OVCAR8 Vitamin K2 photoaffinity probes, after labeling cells, can undergo click chemistry reactions with fluorophores containing azide groups, enabling cell imaging and direct observation of probe labeling and distribution within the cells. Time gradient and competition experiments using MK2P for cell labeling yielded results consistent with previous fluorescent gel imaging experiments. Furthermore, experiments demonstrating co-localization of probe-labeled marker proteins with different organelles within the cells analyzed their intracellular distribution.
[0129] 4.1 Experimental Reagents Sodium chloride (Titan), chloroform (Titan), 4-hydroxyethylpiperazine ethanesulfonic acid (HEPES, Genview), paraformaldehyde (Annegi). t - Octylphenoxypolyethoxyethanol (Triton X-100, Beyotime), Tris(2-carboxyethyl)phosphonic acid hydrochloride (TCEP, Biotech), 2-(4-((bis(1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic acid (BTTAA, Biotech), Copper sulfate (Bitamin B), 1× phosphate buffer (1×PBS, pH=7.4, Thermo Fisher), DMEM (Thermo Fisher), Fetal bovine serum (FBS, ExCell Bio), Penicillin and streptomycin (PS, Thermo Fisher), Bovine serum albumin (BSA, Solarbio), Tween-20 (Tween-20, Beyotime), Dimethyl sulfoxide (DMSO, Sigma), Cell smears (White Shark), DAPI staining solution (BioSharp), Antifluorescence quenching mounting solution (Beyotime), Primary antibody (Proteintech), Fluorescent secondary antibody Alexa Fluor 488 (Proteintech).
[0130] 4.2 Experimental Apparatus Pipettes (Thermo Fisher), microplate reader (Bio-Rad), 365 nm UV lamp (ZF-1), inverted fluorescence microscope (OLYMPUS), clean bench (Shandong Boke), incubator (Thermo Fisher), pH meter (Sartorius), shaker (Dalong), rare cell analyzer (Dragonfly 200).
[0131] 4.3 Experimental Procedure HT1080 cells or OVCAR-8 cells were grown in well plates containing crawler slides. Each well was incubated with DMEM medium containing 10 μmol / L MK2P for 4 hours. For competition experiments, each well was incubated with medium containing 10 μmol / L probe and 100 μmol / L competitor (MK2 or MK4) for 4 hours. The control group was incubated with medium containing the same DMSO concentration. For time-gradient experiments, cells were incubated for different times and then treated uniformly.
[0132] After incubation, remove the culture medium, wash three times with 1×PBS, place the culture dish on ice, and irradiate with a 365 nm UV lamp for 5 minutes. Add 4% paraformaldehyde for fixation at room temperature for 15 minutes, then wash three times with pre-cooled 1×PBS. Add HEPES buffer containing 0.1% Triton X-100 and incubate at room temperature for 20 minutes. Add TCEP, BTTAA, copper sulfate, and Rhodamine B-PEG3-azide to final concentrations of 1 mmol / L, 100 μmol / L, 1 mmol / L, and 10 μmol / L, respectively, and incubate at room temperature for 3 hours. Aspirate the reaction solution, wash three times with 1×PBS, and stain with DAPI staining solution for 5 minutes. Remove the slides from the well plate, place them on a glass slide with anti-fluorescence quenching mounting solution, seal the edges with clear nail polish, and allow to dry before proceeding with fluorescence detection of probe-labeled cells. For colocalization experiments, after the click chemistry reaction is complete, add 1×PBST (0.1% Tween 20) buffer containing 5% BSA and incubate at room temperature for 30 minutes. Then, incubate with primary antibody, fluorescent secondary antibody, and DAPI staining solution sequentially. After mounting, perform the detection.
[0133] 4.4 Results and Discussion 4.4.1 Effect of probe incubation time on cell imaging To investigate the effect of different probe incubation times on MK2P labeling in cell imaging, probe labeling was performed in OVCAR-8 and HT1080 cells at different times. Figure 21Cell imaging results showed that the fluorescence intensity of the vitamin K2 photoaffinity probe in both cell types increased with prolonged incubation time, consistent with the results of fluorescent gel imaging experiments. Fluorescent signals were observed in OVCAR-8 and HT1080 cells after 10 minutes of probe incubation, indicating that the cells could rapidly take up the probe.
[0134] 4.4.2 Effect of Vitamin K on Probe-Labeled Cell Imaging In OVCAR-8 cells, MK2P labeling was competitively performed using MK2 and MK4 at 10-fold probe concentrations, respectively. Figure 22 Cell imaging results showed that the competitive trend was consistent with that of the fluorescent gel. Both MK2 and MK4 significantly reduced the overall fluorescence intensity of MK2P-labeled cells, and the competitive effect of MK2 was slightly stronger than that of MK4.
[0135] 4.4.3 Effects of UV irradiation on probe-labeled cell imaging To investigate the effect of photoreactive groups on probe labeling, the changes in probe labeling were compared under conditions of UV irradiation and without UV exposure. Figure 23 The results showed that, compared to 5 minutes of UV irradiation, the group without UV irradiation still had labels, although the overall fluorescence intensity was weaker. After 4 hours of probe incubation, there was also obvious fluorescence even without UV irradiation, which was consistent with the fluorescent gel results of the control probe.
[0136] 4.4.4 Analysis of intracellular distribution of vitamin K2 using cell imaging To investigate the intracellular distribution of vitamin K2, colocalization analysis was performed on MK2P and marker proteins of organelles such as the endoplasmic reticulum, Golgi apparatus, mitochondria, plasma membrane, and peroxisomes. Figure 24 The results showed that MK2P was significantly co-localized with these organelles, consistent with the cellular component analysis of the mass spectrometry data, indicating that vitamin K2 is distributed in these organelles. This method can also be further used to study the interaction of vitamin K with other proteins and its intracellular function.
[0137] Matters not covered in this invention are common knowledge.
[0138] The above description is merely a preferred embodiment of the present invention and is not intended to limit the invention. Various modifications and variations can be made to the present invention by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.
Claims
1. An isoprene derivative photoaffinity probe, characterized in that, The isoprene derivative photoaffinity probes include photoaffinity geraniol probes (GOHP), photoaffinity farnesol probes (FOHP), or vitamin K2 photoaffinity probes (MK2P), with the following specific structural formulas: 。 2. The method of producing a photoaffinity probe of isoprene derivative according to claim 1, characterized in that, The preparation method includes: S1. Protect the hydroxyl group of geraniol or farnesol with a tetrahydropyranyl group to obtain compound 1; S2. The allyl position of compound 1 was oxidized with selenium dioxide and tert-butyl hydroperoxide, and then reduced with sodium borohydride to obtain compound 2 with a terminal hydroxyl group. S3. The terminal hydroxyl group of compound 2 was brominated using N-bromosuccinimide and dimethyl sulfide to give compound 3; S4. Ethyl acetoacetate was coupled with 3-bromo-1-(trimethylsilyl)-1-propyne in the presence of lithium diisopropylamino to obtain ketoester compound 4 containing an alkyne group. S5. Compound 3 and compound 4 are coupled in the presence of sodium hydride, and then decarboxylated by saponification to obtain compound 5. S6. Remove the tetrahydropyran protecting group of compound 5 to obtain compound 6; S7. The ketone group of compound 6 was successively treated with ammonia-methanol, hydroxylamine-O-sulfonic acid oxime and iodine oxidation cyclization to introduce a diazinon group, thereby obtaining compound 7, namely the photoaffinity geraniol probe or the photoaffinity farnesol probe.
3. The production method according to claim 2, wherein The preparation method further includes: coupling compound 7 photoaffinity geraniol probe with the reduction product of menaquinone under the catalysis of boron trifluoride diethyl ether to obtain vitamin K2 photoaffinity probe.
4. The production method according to claim 2, wherein The preparation method includes the following synthetic route: 。 5. The production method according to claim 4, wherein The synthetic route also includes: 。 6. A test kit characterized in that, The kit includes the isoprene derivative photoaffinity probe as described in claim 1.
7. The application of the isoprene derivative photoaffinity probe of claim 1 or the detection kit of claim 6 in protein labeling and identification; further, the protein includes isoprene-modified protein and / or vitamin K-binding protein.
8. Use according to claim 7, wherein the compound is ###0002### The applications include: co-incubating the isoprene derivative photoaffinity probe with cells to modify proteins with isoprene or bind to vitamin K binding proteins within the cells; covalently crosslinking the probe with its binding protein via a diaziridine group after ultraviolet irradiation; introducing a fluorescent group or biotin onto the alkyne group of the probe via a click chemistry reaction; and using it for fluorescence gel imaging analysis, cell fluorescence imaging analysis, or proteomics mass spectrometry analysis after streptavidin enrichment.
9. Use according to claim 8, wherein the compound is ###0002### The fluorescent group is selected from Rhodamine B-PEG3-azide; the biotin is selected from Biotin-DADPS-azide. Furthermore, when the probe is co-incubated with cells, lovastatin is added to inhibit endogenous isoprene synthesis; Furthermore, the applications include research on the mechanisms of action of drugs related to the isopentenyl pathway; Furthermore, the application also includes studying the distribution of vitamin K within cells.
10. Use according to claim 9, wherein The cells include HEK 293T cells, HT1080, or OVCAR8.
